JPH0222059B2 - - Google Patents
Info
- Publication number
- JPH0222059B2 JPH0222059B2 JP55145549A JP14554980A JPH0222059B2 JP H0222059 B2 JPH0222059 B2 JP H0222059B2 JP 55145549 A JP55145549 A JP 55145549A JP 14554980 A JP14554980 A JP 14554980A JP H0222059 B2 JPH0222059 B2 JP H0222059B2
- Authority
- JP
- Japan
- Prior art keywords
- nitrophenyl
- benzoyl
- solution
- acid
- mol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 claims description 24
- -1 ethyl 3-benzoyl-2-nitrophenyl Chemical group 0.000 claims description 23
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- GCWNYHQPWKBAFT-UHFFFAOYSA-N 2-(3-benzoyl-2-nitrophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1[N+]([O-])=O GCWNYHQPWKBAFT-UHFFFAOYSA-N 0.000 claims description 10
- 150000001768 cations Chemical class 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052736 halogen Chemical group 0.000 claims description 3
- 150000002367 halogens Chemical group 0.000 claims description 3
- HGIRZIGBWAKVRS-UHFFFAOYSA-N 2-[3-(4-chlorobenzoyl)-2-nitrophenyl]acetic acid Chemical compound OC(=O)CC1=CC=CC(C(=O)C=2C=CC(Cl)=CC=2)=C1[N+]([O-])=O HGIRZIGBWAKVRS-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- RZOYISMAVUREIE-UHFFFAOYSA-N 2-(3-benzoyl-2-nitrophenyl)acetamide Chemical compound NC(=O)CC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1[N+]([O-])=O RZOYISMAVUREIE-UHFFFAOYSA-N 0.000 claims 1
- DJIUYVLSADTHEZ-UHFFFAOYSA-N 2-(3-benzoyl-2-nitrophenyl)propanoic acid Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1[N+]([O-])=O DJIUYVLSADTHEZ-UHFFFAOYSA-N 0.000 claims 1
- 239000000243 solution Substances 0.000 description 40
- 239000000203 mixture Substances 0.000 description 28
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 27
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- 239000007787 solid Substances 0.000 description 21
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 239000004480 active ingredient Substances 0.000 description 11
- 238000002844 melting Methods 0.000 description 11
- 230000008018 melting Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 8
- 229910052938 sodium sulfate Inorganic materials 0.000 description 8
- 235000011152 sodium sulphate Nutrition 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 150000001408 amides Chemical class 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 4
- BXRFQSNOROATLV-UHFFFAOYSA-N 4-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(C=O)C=C1 BXRFQSNOROATLV-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- OZBWMJWUXGXBLV-UHFFFAOYSA-N diethyl 2-(3-benzoyl-2-nitrophenyl)propanedioate Chemical compound CCOC(=O)C(C(=O)OCC)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1[N+]([O-])=O OZBWMJWUXGXBLV-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229960000905 indomethacin Drugs 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 4
- WCSSWDYRZSVJJD-UHFFFAOYSA-N (3-chloro-2-nitrophenyl)-(4-chlorophenyl)methanone Chemical compound [O-][N+](=O)C1=C(Cl)C=CC=C1C(=O)C1=CC=C(Cl)C=C1 WCSSWDYRZSVJJD-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 239000004533 oil dispersion Substances 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- YIIGXLDRGDPCFZ-UHFFFAOYSA-N (2-amino-3-chlorophenyl)-(2,4-dichlorophenyl)methanone Chemical compound NC1=C(Cl)C=CC=C1C(=O)C1=CC=C(Cl)C=C1Cl YIIGXLDRGDPCFZ-UHFFFAOYSA-N 0.000 description 2
- NORQKWBDRFASAJ-UHFFFAOYSA-N (2-amino-3-chlorophenyl)-(4-chlorophenyl)methanone Chemical compound NC1=C(Cl)C=CC=C1C(=O)C1=CC=C(Cl)C=C1 NORQKWBDRFASAJ-UHFFFAOYSA-N 0.000 description 2
- ZTCIBLJCYHPNFZ-UHFFFAOYSA-N (2-amino-3-chlorophenyl)-(4-methoxyphenyl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=CC=CC(Cl)=C1N ZTCIBLJCYHPNFZ-UHFFFAOYSA-N 0.000 description 2
- JEXAKDBZSUOCSH-UHFFFAOYSA-N (2-amino-3-chlorophenyl)-(4-methylphenyl)methanone Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=CC(Cl)=C1N JEXAKDBZSUOCSH-UHFFFAOYSA-N 0.000 description 2
- JCPSDGBPFXACKB-UHFFFAOYSA-N (2-amino-3-chlorophenyl)-phenylmethanone Chemical compound NC1=C(Cl)C=CC=C1C(=O)C1=CC=CC=C1 JCPSDGBPFXACKB-UHFFFAOYSA-N 0.000 description 2
- XXRFFUVWUQFETH-UHFFFAOYSA-N (3-chloro-2-nitrophenyl)-(2,4-dichlorophenyl)methanone Chemical compound [O-][N+](=O)C1=C(Cl)C=CC=C1C(=O)C1=CC=C(Cl)C=C1Cl XXRFFUVWUQFETH-UHFFFAOYSA-N 0.000 description 2
- INSZUXYMOIBUDM-UHFFFAOYSA-N (3-chloro-2-nitrophenyl)-(4-methoxyphenyl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=CC=CC(Cl)=C1[N+]([O-])=O INSZUXYMOIBUDM-UHFFFAOYSA-N 0.000 description 2
- QMMAIZDAVUDVFD-UHFFFAOYSA-N (3-chloro-2-nitrophenyl)-(4-methylphenyl)methanone Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=CC(Cl)=C1[N+]([O-])=O QMMAIZDAVUDVFD-UHFFFAOYSA-N 0.000 description 2
- HJAIUBPFHBLXFF-UHFFFAOYSA-N (3-chloro-2-nitrophenyl)-phenylmethanone Chemical compound [O-][N+](=O)C1=C(Cl)C=CC=C1C(=O)C1=CC=CC=C1 HJAIUBPFHBLXFF-UHFFFAOYSA-N 0.000 description 2
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 2
- MXVAMFYSKAUGSC-UHFFFAOYSA-N 2-(4-benzoyl-2-nitrophenyl)acetic acid Chemical compound C1=C([N+]([O-])=O)C(CC(=O)O)=CC=C1C(=O)C1=CC=CC=C1 MXVAMFYSKAUGSC-UHFFFAOYSA-N 0.000 description 2
- AKCRQHGQIJBRMN-UHFFFAOYSA-N 2-chloroaniline Chemical compound NC1=CC=CC=C1Cl AKCRQHGQIJBRMN-UHFFFAOYSA-N 0.000 description 2
- GJNGXPDXRVXSEH-UHFFFAOYSA-N 4-chlorobenzonitrile Chemical compound ClC1=CC=C(C#N)C=C1 GJNGXPDXRVXSEH-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
- 206010053155 Epigastric discomfort Diseases 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 235000013539 calcium stearate Nutrition 0.000 description 2
- 239000008116 calcium stearate Substances 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- 229940038472 dicalcium phosphate Drugs 0.000 description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
- WXPCTCAKMSEMNK-UHFFFAOYSA-N diethyl 2-[3-(4-chlorobenzoyl)-2-nitrophenyl]propanedioate Chemical compound CCOC(=O)C(C(=O)OCC)C1=CC=CC(C(=O)C=2C=CC(Cl)=CC=2)=C1[N+]([O-])=O WXPCTCAKMSEMNK-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000008174 sterile solution Substances 0.000 description 2
- 239000012258 stirred mixture Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- FAQYAMRNWDIXMY-UHFFFAOYSA-N trichloroborane Chemical compound ClB(Cl)Cl FAQYAMRNWDIXMY-UHFFFAOYSA-N 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- YSFBEAASFUWWHU-UHFFFAOYSA-N 2,4-dichlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C(Cl)=C1 YSFBEAASFUWWHU-UHFFFAOYSA-N 0.000 description 1
- JYJIMEQNTHFXMT-UHFFFAOYSA-N 2-nitro-2-phenylacetic acid Chemical compound OC(=O)C([N+]([O-])=O)C1=CC=CC=C1 JYJIMEQNTHFXMT-UHFFFAOYSA-N 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- IYXGSMUGOJNHAZ-UHFFFAOYSA-N Ethyl malonate Chemical compound CCOC(=O)CC(=O)OCC IYXGSMUGOJNHAZ-UHFFFAOYSA-N 0.000 description 1
- 208000009386 Experimental Arthritis Diseases 0.000 description 1
- 206010017788 Gastric haemorrhage Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002151 Pleural effusion Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- SOYCMDCMZDHQFP-UHFFFAOYSA-N amfenac Chemical class NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=CC=C1 SOYCMDCMZDHQFP-UHFFFAOYSA-N 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- KQOQOOGWUYEODW-UHFFFAOYSA-N diethyl 2-(3-benzoyl-2-nitrophenyl)-2-methylpropanedioate Chemical compound CCOC(=O)C(C)(C(=O)OCC)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1[N+]([O-])=O KQOQOOGWUYEODW-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- HCPOCMMGKBZWSJ-UHFFFAOYSA-N ethyl 3-hydrazinyl-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)NN HCPOCMMGKBZWSJ-UHFFFAOYSA-N 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- FXLOVSHXALFLKQ-UHFFFAOYSA-N p-tolualdehyde Chemical compound CC1=CC=C(C=O)C=C1 FXLOVSHXALFLKQ-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doublyâbound oxygen atom, not being part of a âCHO group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯æãçš®ã®æ°èŠãªïŒâãã³ãŸã€ã«âïŒâ
ãããããšãã«é ¢é žããã³èªå°äœïŒéå±å¡©ãã¢ã
ãããã³ãšã¹ãã«é¡ïŒãããããçšããæ²»çæ³ã
è¬å€çµæç©ããã³ãã®çšéããªãã³ã«ãããã®å
åç©ããã³æ°èŠäžéäœã®è£œé æ³ã«é¢ãããæ¬çºæ
ã®ïŒâãã³ãŸã€ã«âïŒâãããããšãã«é ¢é žãã
ã³èªå°äœã¯ãåç©çäœãžã®å çšã«ãããæãŸãã
ãªãå¯äœçšãæå°éãããªãæ¶çå€ã§ããã æççäœçšãæããïŒâã¢ããâïŒâãã³ãŸã€
ã«ããšãã«é ¢é žãªãã³ã«ãã®ãšã¹ãã«ããã³éå±
å¡©ã¯ç±³åœç¹èš±4045576ã«é瀺ãããŠããã æ¬çºæã®ååç©ã®ç°æ§äœã§ããïŒâãã³ãŸã€ã«
âïŒâãããããšãã«é ¢é žã¯BeilsteinïŒææ©å
åŠ10ã361ïŒ1910â1919ïŒã«å ±åãããŠããã å¥ã®ç°æ§äœã§ããïŒâãã³ãŸã€ã«âïŒâããã
ããšãã«âïŒâããããªã³é žã¯ãFenic et al.J.
Het.Chem.14ã1225ïŒ1977ïŒã®ãã³ãŸãžã¢ãŒãã³
ã®è£œé ã«ãããäžéäœãšããŠå ±åãããŠããã åŸæ¥ã匷åãªæççè¬å€ã¯ãæå¹ç¯å²å ã®éã§
人ããã³åç©ã«çµå£æäžãããšãã«äžè¬ã«èã®åº
è¡ããã³æœ°ç圢æãšããé倧ãªå¯äœçšãçããã
ãšãèªããããŠãããæ¬çºæã®ååç©ã¯ãççã
ç·©åããããã«æå¹ç¯å²å ã®éã§æäžããå Žåã«
èªããããèã®åºæ¿ã®çºççããã€ã³ãã¡ã¿ã·ã³
ããã³ç±³åœç¹èš±4045576ã«é瀺ãããïŒâã¢ãã
âïŒâãã³ãŸã€ã«ããšãã«é ¢é žã«æ¯ã¹ãŠäœããšã
ãå©ç¹ãæããããšãå€æããã æççäœçšã瀺ãæ¬çºæã®æ°èŠååç©ã¯ãäžè¬
ã«äžèšäžè¬åŒã§ç€ºãããïŒâãã³ãŸã€ã«âïŒâ
ãããããšãã«é ¢é žãéå±å¡©ãã¢ããããã³ãšã¹
ãã«é¡ã§ããã äžèšåŒäžã R1ã¯æ°ŽçŽ ãŸãã¯äœçŽã¢ã«ãã«ã R2ã¯OHãOMãâäœçŽã¢ã«ãã«ãNH2ã
NHâäœçŽã¢ã«ãã«ãŸãã¯âïŒïŒ®âãžäœçŽã¢ã«
ãã«ã ã¯æ°ŽçŽ ãŸãã¯ããã²ã³ã ïŒã¯å»è¬ãšããŠèš±å®¹ãããã«ããªã³ãããã¯å€
䟡ã«ããªã³ã®å Žåã¯ã«ããªã³ã®äžéšåããŸãã¯ã
ã®æ°Žåç©ã ïœã¯ïŒãïŒã®æŽæ°ãããããæå³ããã æ¬çºæã«ããæäŸãããå¥ã®æ°èŠååç©ã¯ãæ¬
çºæã®äžèšæççæ§ååç©ã®è£œé çšäžéäœã§ãã
äžèšäžè¬åŒã§ç€ºãããïŒâïŒïŒâãã³ãŸã€ã«â
ïŒâãããããšãã«ïŒã¢ã«ã«ã³äºé žãžã¢ã«ãã«ãš
ã¹ãã«ã§ããã äžèšåŒäžãR1ãšïŒžã¯åèšå®çŸ©ã®ãšããã§ããã äžè¬åŒã®ååç©ãšããŠã¯ãäœçŽã¢ã«ãã«ããš
ãã«ã§ããååç©ã奜ãŸããã æ¬æ现æžã«ãããäžè¬åŒã§çšããèšå·ã®å®çŸ©ã«
ãããŠã䜿çšãããŠããåçšèªã®æå³ã¯æ¬¡ã®ãšã
ãã§ããã ãäœçŽã¢ã«ãã«ããšã¯ãççŽ æ°ïŒãŸã§ã®çŽéã
ãã³åå²éã®åºãå å«ãããã®äŸãšããŠã¯ã¡ã
ã«ããšãã«ããããã«ãã€ãœãããã«ãããã«ã
secâããã«ãtertâããã«ãã¢ãã«ãã€ãœã¢ã
ã«ãããã·ã«ããããã«ããã³ãªã¯ãã«ãªã©ã®åº
ãæããããããäœçŽã¢ã«ã³ãã·ããšã¯ãåŒâ
âäœçŽã¢ã«ãã«ã§ç€ºãããåºã§ããã æ¬æ现æžã§èšåããå Žåã®ãããã²ã³ããšã¯ã
ããçŽ ãå¡©çŽ ãèçŽ ããã³ãšãŠçŽ ã奜ãŸããã¯ã
ãçŽ ãå¡©çŽ ããã³èçŽ ãå å«ããã æ¬æ现æžã§èšåããå Žåã®é žã®å¡©ã圢æãã
ãå»è¬ãšããŠèš±å®¹ãããã«ããªã³ãããã³ãã®æ°Ž
åç©ãšã¯ãããšãã°ãããªãŠã ãã«ãªãŠã ãã«ã«
ã·ãŠã ããã°ãã·ãŠã ãäºéãé ããã³ã¢ã«ãã
ãŠã ãªã©ã®ä»»æã®å»è¬ãšããŠèš±å®¹ãããéå±ã«ã
ãªã³ãªãã³ã«æ°Žåæ°Žãå å«ããããããªãŠã ã«ã
ãªã³ã奜ãŸããã æçç掻æ§ã¯ã(1)L.F.SancilioãJ.Pharmacol.
Exp.Ther.168ïŒ199â204ïŒ1969ïŒã«èšèŒã®ãšãã³
ã¹éã«ã©ãžãŒãã³èžè滲åºæ¶²åææ³ã®å€æ³ã(2)
Walz et alïŒJ.Pharmacol.Exp.Ther.178ïŒ223â
231ã«èšèŒã®ã©ããã«ãããè£å©è¬èªçºé¢ç¯çæ³ã
ããã³(3)Winter et alïŒProc.Soc.Exp.Biol.Med.
111ïŒ544â547ïŒ1962ïŒã«èšèŒã®ã«ã©ãžãŒãã³èªçº
è¶³æµ®è «æ³ãçšããŠå®éšåç©ã«ãããŠå®èšŒãããã äžèšã®èžè滲åºæ¶²åææ³ã§ã€ã³ãã¡ã¿ã·ã³ãšæ¯
èŒè©Šéšããå Žåãæ¬çºæã®ååç©ã¯äžè¬ã«ã€ã³ã
ã¡ã¿ã·ã³ããå¹åãããäœãããèãžã®åºæ¿ã¯ã€
ã³ãã¡ã¿ã·ã³ã§èªãããããã®ã®ã»ãã®ããäžéš
ãã瀺ããªãã€ãã äžã§è¿°ã¹ãç°æ§äœïŒâãã³ãŸã€ã«âïŒâããã
ããšãã«é ¢é žã補é ããè©Šéšãããšããããšãã³
ã¹éã«ã©ãžâãã³èžè滲åºåææ³ã«ãããŠ100
mgïŒKgã§ãæçç掻æ§ããŸã€ããæããŠããªãã
ãšãå€æãããããã«å¯ŸããŠãåŸåºã®å®æœäŸïŒã®
ååç©ã¯ïŒmgïŒKgã§åŒ·ã掻æ§ã瀺ããã ãã€ãŠãæ¬çºæã®ç®çã¯æ°èŠãªïŒâãã³ãŸã€ã«
âïŒâãããããšãã«é ¢é žããã®å¡©ããã³æ°Žå
ç©ãã¢ãããªãã³ã«ãšã¹ãã«é¡ãæäŸããããšã§
ããã å¥ã®ç®çã¯ãïŒâãã³ãŸã€ã«âïŒâãããããš
ãã«é ¢é žããã®ã¢ããããã³ãšã¹ãã«ãçšããã
èè žéšãžã®æãŸãããªãå¯äœçšãæå°éã«æããŠ
ççãç·©åããããã®çäœãç¹ã«äººãå«ãåºä¹³å
ç©ã®çäœã®æ°èŠãªæ²»çæ³ããªãã³ã«ãã®ããã®æ²»
ççšçµæç©ãæäŸããããšã§ããã æ¬çºæã®ãŸãå¥ã®ç®çã¯æ°èŠãªäžéäœãæäŸã
ãããšã§ããã ããã«å¥ã®ç®çãåœæ¥è ã«ã¯æããã§ãããã
ã®ä»ã®ç®çã¯ä»¥äžã®èšèŒããæãããšãªããã äžèšäžè¬åŒã®äžéäœã¯äžèšã®åå¿åŒã«ããã
ã€ãŠè£œé ãããïŒ ïŒåŒäžããšïœã¯åèšå®çŸ©ã®ãšããïŒãäžè¬åŒ
ïœãšïœã¯äžè¬åŒã«å å«ãããã R2ãOHãŸãã¯OMã§ããäžè¬åŒã®ïŒâãã³
ãŸã€ã«âïŒâãããããšãã«é ¢é žãšéå±å¡©ã¯ãäž
èšã®åå¿åŒã«ãããã€ãŠè£œé ãããïŒ ïŒåŒäžãR1ïŒïŒžïŒïœããã³ïŒã¯åèšå®çŸ©ã®ãš
ããïŒã éé¢ã®ïŒâãã³ãŸã€ã«âïŒâãããããšãã«é ¢
é žã¯ãäžèšã®åå¿åŒã«ãããã€ãŠãã¢ããïŒR2
ïŒNH2ïŒãäœçŽã¢ã«ãã«ã¢ããïŒR2ïŒNHâäœçŽ
ã¢ã«ãã«ïŒããžäœçŽã¢ã«ãã«ã¢ãããR2ïŒïŒ®â
ïŒäœçŽã¢ã«ãã«ïŒ2ãããã³ãšã¹ãã«ïŒR2ïŒïŒ¯âäœ
çŽã¢ã«ãã«ïŒã«è»¢åãããããšãã§ããïŒ ïŒåŒäžãR1ïŒïŒžããã³ïœã¯åèšå®çŸ©ã®ãšã
ãïŒãäžè¬åŒïœãªããïœã¯ããããäžè¬åŒ
ã«å å«ãããã æ¬çºæã®ïŒâãã³ãŸã€ã«âïŒâãããããšãã«
é ¢é žã補é ããã®ã«çšããããäžèšäžè¬åŒã®åº
çºç©è³ªã¯æ¬¡ã®åå¿åŒã§ç€ºãæ¹æ³ã«ãã補é ã§ã
ãïŒ ïŒåŒäžããšïœã¯åèšå®çŸ©ã®ãšããïŒã åºçºç©è³ªããã³ã®è£œé æ³ã¯äžèšã®è£œé äŸã«
ãã詳ãã説æãããŠããã 補é äŸ ïŒ ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒããšãã«
ã¡ã¿ãã³ ïŒïŒïŒïŒïŒïŒïŒâããã©ã¯ãããšã¿ã³200mläž
ã®ïŒâã¯ããã¢ããªã³36.1ïœïŒ0.30ã¢ã«ïŒã®å·æº¶
液ã«ãäžå¡©åããŠçŽ 34.0ïœïŒ0.33ã¢ã«ïŒã®ããã©
ã¯ãããšã¿ã³ïŒ150mlïŒå·æº¶æ¶²ããã³ãŸãããªã«
60mlïŒ0.6ã¢ã«ïŒããã³äžå¡©åã¢ã«ãããŠã 44.0
ïœïŒ0.33ã¢ã«ïŒãé ã«å ãããåŸããã溶液ãïŒ
æééæµå ç±ããå·åŽåŸã«2Nå¡©é ž200mlã§åŠç
ããããã«0.5æéèžæ°æµŽå ç±ãããçžåé¢ãã
åŸãææ©å±€ãç¡«é žãããªãŠã ã§ä¹Ÿç¥ããæ¿çž®ã
ããæ®æž£ã100âããã³0.2mmïœã§ç空èžçã
ããã«ãæ®ãã·ãªã«ã²ã«250ïœã§ã¯ãããã°ã©ã
åŠçããŠã43.6ïœïŒ63ïŒ ïŒã®é»è²ç²æ«ãåŸããè
ç¹54ã56âïŒãªã°ãã€ã³ããåçµæ¶åŸïŒã åæå€ïŒC13H10ClNO èšç®å€ïŒïŒ£ïŒ67.40ïŒïŒšïŒ4.35ïŒïŒ®ïŒ6.05 å®æž¬å€ïŒïŒ£ïŒ67.41ïŒïŒšïŒ4.35ïŒïŒ®ïŒ6.06 補é äŸ ïŒ ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒâã¯
ããããšãã«ïŒã¡ã¿ãã³ ïŒïŒïŒïŒïŒïŒïŒâããã©ã¯ãããšã¿ã³100mläž
ã®ïŒâã¯ããã¢ããªã³44.4ïœïŒ0.35ã¢ã«ïŒã®å·æº¶
液ã«ãããã©ã¯ãããšã¿ã³100mläžã®äžå¡©åããŠ
çŽ 44.6ïœïŒ0.38ã¢ã«ïŒã®æº¶æ¶²ã次ãã§ããã©ã¯ã
ããšã¿ã³225mläžã®ïŒâã¯ãããã³ãŸãããªã«100
ïœïŒ0.73ã¢ã«ïŒã®æº¶æ¶²ããã³äžå¡©åã¢ã«ãããŠã
50.5ïœïŒ0.38ã¢ã«ïŒãå ãããåŸããã溶液ãïŒ
æééæµå ç±ããåŸãå·åŽãã2Nå¡©é ž240mlã§åŠ
çããããã«0.5æéèžæ°æµŽå ç±ãããåå¿æ··å
ç©ãå·åŽããã»ã©ã€ãã§éããã液ãçžåé¢
ããææ©å±€ãæ¿çž®ãããæ®æž£ã100âããã³02mm
ïœã§ç空èžçãããã«ãæ®ïŒ105ïœïŒã400ïœã®
ã·ãªã«ã²ã«ã§ã¯ãããã°ã©ãåŠçããŠã58.4ïœã®
æ²¹ç¶ç©ãåŸããããã¯çµæ¶åãããåŸãããåºäœ
ãã€ãœãããã«ã¢ã«ã³ãŒã«ããïŒååçµæ¶ããŠã
33.0ïœïŒ35ïŒ ïŒã®é»è²éç¶çµæ¶ãåŸããèç¹85
âã åæå€ïŒC13H9Cl2NO èšç®å€ïŒïŒ£ïŒ58.67ïŒïŒšïŒ3.41ïŒïŒ®ïŒ5.26 å®æž¬å€ïŒïŒ£ïŒ58.73ïŒïŒšïŒ3.38ïŒïŒ®ïŒ5.31 補é äŸ ïŒ ïŒïŒâã¯ããâïŒâãããããšãã«ïŒããšãã«
ã¡ã¿ãã³ 90ïŒ éé žåæ°ŽçŽ 10.8mlãšå¡©åã¡ãã¬ã³250mlã
ããªãå·åŽã»æ¹æãããæ··åç©ã«ãç¡æ°Žããªãã«
ãªãé ¢é ž100ïœïŒ67.6mlïŒã45åéãããŠæ»Žäžã
ãã氷济ãåãã¯ãããå¡©åã¡ãã¬ã³100mläžã®
ç²è£œïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒããšã
ã«ã¡ã¿ãã³23.1ïœïŒ0.1ã¢ã«ïŒã®æº¶æ¶²ã45åéã
ããŠæ»ŽäžãããåŸãããé»ããã 溶液ãïŒæéèž
æ°æµŽå ç±ããåŸãå·åŽããå·æ°Žå200mlã§ïŒåã
å·10ïŒ çé žãããªãŠã ïŒä¹³æ¿æ¶²ïŒå200mlã§ïŒå
ããã³é£œåå¡©åãããªãŠã 溶液ã§ïŒåã®é ã«æŽæµ
ãããæŽæµåŸã®å¡©åã¡ãã¬ã³æº¶æ¶²ãç¡«é žãããªãŠ
ã ã§ä¹Ÿç¥ããæ¿çž®ããŠã19.6ïœã®æ²¹ç¶æ®æž£ãåŸ
ãããã®æ²¹ç¶ç©ã250ïœã®ã·ãªã«ã²ã«ã§ã¯ããã
ã°ã©ãåŠçããŠã15.3ïœïŒ59ïŒ ïŒã®æ²¹ç¶ç©ãåŸ
ãããã®çæç©ã¯ãåšå£ã®ãããã«ããçµæ¶åã
ãããã®åºäœãã€ãœãããããŒã«ããåçµæ¶ã
ãŠãé»è€è²ã®åºäœãåŸãã èç¹67ã69âã åæå€ïŒC13H8ClNO3 èšç®å€ïŒïŒ£ïŒ59.67ïŒïŒšïŒ3.08ïŒïŒ®ïŒ5.35 å®æž¬å€ïŒïŒ£ïŒ59.78ïŒïŒšïŒ3.06ïŒïŒ®ïŒ5.35 補é äŸ ïŒ ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒâã¯
ããããšãã«ïŒã¡ã¿ãã³ 90ïŒ éé žåæ°ŽçŽ 10.0mlãšå¡©åã¡ãã¬ã³250mlãš
ã®å·åŽã»æ¹æãããæ··åç©ã«ãç¡æ°Žããªãã«ãªã
é ¢é ž100ïœãïŒæéãããŠæ»Žäžããã氷济ãåã
ã¯ãããå¡©åã¡ãã¬ã³100mläžã®ïŒïŒâã¢ããâ
ïŒâã¯ããããšãã«ïŒïŒïŒâã¯ããããšãã«ïŒã¡
ã¿ãã³26.6ïœïŒ0.10ã¢ã«ïŒã®æº¶æ¶²ãïŒæéãããŠ
滎äžãããåŸãããé»ããã 溶液ãïŒæéèžæ°æµŽ
å ç±ããå·åŽããé ã«å·æ°Žå200mlã§ïŒåãå·10
ïŒ çé žãããªãŠã å200mlã§ïŒåããã³é£œåå¡©å
ãããªãŠã 溶液ã§ïŒåæŽæµãããæŽæµããå¡©åã¡
ãã¬ã³å±€ãç¡«é žãããªãŠã ã§ä¹Ÿç¥ããæ¿çž®ããŠã
é»è€è²åºäœ19.9ïœãæ®æž£ãšããŠåŸãããã®åºäœã
ã·ãªã«ã²ã«400ïœã§ã¯ãããã°ã©ãåŠçããŠãç®
çãšããçæç©11.9ïœïŒ40ïŒ ïŒãåŸããäžéšãã¢
ã»ããããªã«ããïŒåãç¡æ°Žãšã¿ããŒã«ããïŒå
åçµæ¶ãããšãèç¹147ã148âã®åæçšè©Šæãçœ
è²åºäœãšããŠåŸãããã åæå€ïŒC13H7Cl2NO3 èšç®å€ïŒïŒ£ïŒ52.73ïŒïŒšïŒ2.38ïŒïŒ®ïŒ4.73 å®æž¬å€ïŒïŒ£ïŒ53.11ïŒïŒšïŒ2.38ïŒïŒ®ïŒ4.85 補é äŸ ïŒ è£œé äŸïŒã®æ¹æ³ã«ãããã€ãŠããã ãïŒâã¯ã
ããã³ãŸãããªã«ã«ä»£ããŠçã¢ã«éã®äžèšåå
ç©ïŒ ïŒïŒïŒâãžã¯ããããšãã«ã¡ã¿ãã³ã ïŒâã¡ãã«ããšãã«ã¡ã¿ãã³ã ïŒâã¡ããã·ããšãã«ã¡ã¿ãã³ãããã³ ïŒâãããããšãã«ã¡ã¿ãã³ã ã䜿çšãããšãäžèšçæç© ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒïŒïŒ
âãžã¯ããããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒâã¡
ãã«ããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒâã¡
ããã·ããšãã«ïŒã¡ã¿ãã³ãããã³ ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒâã
ããããšãã«ïŒã¡ã¿ãã³ã ãåŸãããã 補é äŸ ïŒ è£œé äŸïŒã®æ¹æ³ã«ãããã€ãŠããã ãïŒïŒâã¢
ããâïŒâã¯ããããšãã«ïŒïŒïŒâã¯ããããš
ãã«ïŒã¡ã¿ãã³ã«ä»£ããŠçã¢ã«éã®äžèšåå
ç©ïŒ ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒïŒïŒ
âãžã¯ããããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒâã¡
ãã«ããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒâã¡
ããã·ããšãã«ïŒã¡ã¿ãã³ãããã³ ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒâã
ããããšãã«ïŒã¡ã¿ãã³ ã䜿çšãããšãäžèšçæç©ïŒ ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒïŒïŒ
âãžã¯ããããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒâã¡
ãã«ããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒâã¡
ããã·ããšãã«ïŒã¡ã¿ãã³ãããã³ ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒâã
ããããšãã«ïŒã¡ã¿ãã³ ãåŸãããã äžèšå補é äŸã«ãããŠã¯ãçæç©ãã¯ãããã°
ã©ãåŠçã«ããåé¢ãããããã®åé¢ã¯æ¬¡ã®ãã
ã«ããŠè¡ãªã€ãã溶åºïŒelutionïŒã¯åãã«ãã³
ãŒã³ãšãªã°ãã€ã³ïŒé«æ²žç¹ïŒ60â110âïŒç³æ²¹ãš
ãŒãã«ïŒãšã®æ··åç©ãçšããŠè¡ãªãã次ãã§çŽç²
ã®ãã³ãŒã³ãçšãçæç©ãã«ã©ã ããåé¢ããã æ¬çºæã®æ°èŠååç©ãšãã®è£œæ³ãäžèšã®å®æœäŸ
ã«ããããã«è©³ããäŸç€ºããããã ããæ¬çºæã®
ç¯å²ã¯ãããã«å¶éããããã®ã§ã¯ãªãã å®æœäŸ ïŒ ïŒâïŒïŒâãã³ãŸã€ã«âïŒâãããããšãã«ïŒ
ãããã³äºé žãžãšãã«ãšã¹ãã« ç³æ²¹ãšãŒãã«ã§æŽæµæžã¿ã®57ïŒ æ°ŽçŽ åãããªãŠ
ã ïŒæ²¹åæ£æ¶²1.9ïœïŒ0.044ã¢ã«ïŒãšä¹Ÿç¥ãžã¡ãã«
ã¹ã«ããã·ã25mlãšã®æ··åç©ã100âã«å ç±ãã
ãžã¡ãã«ã¹ã«ããã·ã25mläžã®ããã³é žãžãšãã«
7.0ïœïŒ0.044ã¢ã«ïŒã®æº¶æ¶²ã§åŠçããããã®æ··å
ç©ããåºåœ¢åããã¹ãŠæº¶è§£ããŠããŸããŸã§æ¹æã
ãåŸããžã¡ãã«ã¹ã«ããã·ã15mläžã®ïŒïŒâã¯ã
ãâïŒâãããããšãã«ïŒããšãã«ã¡ã¿ãã³5.4
ïœïŒ0.021ã¢ã«ïŒã®æº¶æ¶²ãå ãããåŸãããé»ã
ãã 溶液ã100âã«ïŒæéå ç±ããåŸã800mlã®æ°·
æ°Žäžã«æå ¥ããããã®æ··åç©ãå100mlã®ãã³ãŒ
ã³ã§ïŒåæœåºããåãããæœåºæ¶²ãæ°Žã§ïŒåã飜
åå¡©åãããªãŠã 溶液ã§ïŒåæŽæµããç¡«é žãããª
ãŠã ã§ä¹Ÿç¥ããæ¿çž®ããŠãåºäœæ®æž£ãåŸãããã®
åºäœãã€ãœãããããŒã«ããåçµæ¶ããŠã3.1ïœ
ïŒ46ïŒ ïŒã®çæç©ãåŸããèç¹130ã131âã åæå€ïŒC20H19NO7 èšç®å€ïŒïŒ£ïŒ62.34ïŒïŒšïŒ4.97ïŒïŒ®ïŒ3.64 å®æž¬å€ïŒïŒ£ïŒ62.31ïŒïŒšïŒ5.03ïŒïŒ®ïŒ3.60 å®æœäŸ ïŒ ïŒâãïŒâïŒïŒâã¯ãããã³ãŸã€ã«ïŒâïŒâã
ããããšãã«ããããã³äºé žãžãšãã«ãšã¹ãã« ç³æ²¹ãšãŒãã«ã§æŽæµæžã¿ã®50ïŒ æ°ŽçŽ åãããªãŠ
ã ïŒæ²¹åæ£æ¶²3.9ïœïŒ0.080ã¢ã«ïŒãšãžã¡ãã«ã¹ã«
ããã·ã50mlãšã®æ··åç©ã100âã«å ç±ãããžã¡
ãã«ã¹ã«ããã·ã15mläžã®ããã³é žãžãšãã«12.8
ïœïŒ0.080ã¢ã«ïŒã®æº¶æ¶²ã§åŠçãããåºäœåãã
ã¹ãŠæº¶è§£ãããŸã§æ··åç©ãæ¹æããåŸããžã¡ãã«
ã¹ã«ããã·ã35mläžã®ïŒïŒâã¯ããâïŒâããã
ããšãã«ïŒïŒïŒâã¯ããããšãã«ïŒã¡ã¿ãã³11.0
ïœïŒ0.037ã¢ã«ïŒã®æº¶æ¶²ãå ãããåŸãããé»ã
ãã 溶液ã90ã100âã«ïŒæéå ç±ããåŸãæ°ŽïŒ
ã«æå ¥ããïŒæ©æŸçœ®ãããåºäœïŒ5.5ïœïŒã
å¥ããã液ãïŒåãã³ãŒã³ã§æœåºãããåãã
ãæœåºæ¶²ãæ°Žãšé£œåå¡©åãããªãŠã 溶液ã§æŽæµ
ããç¡«é žãããªãŠã ã§ä¹Ÿç¥ããæ¿çž®ããŠãæ²¹ç¶æ®
枣ãåŸãããã®æ²¹ç¶ç©ãå°éã®ã€ãœãããã«ã¢ã«
ã³ãŒã«ã«æº¶è§£ããå ã«å¥ããåºäœã®äžéšãçš®æ¶
ãšããŠå ããŠçµæ¶åããããããã«3.1ïœã®çæ
ç©ãåŸãããåèšã®åºäœåéã¯8.6ïœïŒ55ïŒ ïŒãš
ãªã€ããèç¹96ã100âã åæå€ïŒC20H18ClNO7 èšç®å€ïŒïŒ£ïŒ57.22ïŒïŒšïŒ4.32ïŒïŒ®ïŒ3.34 å®æž¬å€ïŒïŒ£ïŒ57.19ïŒïŒšïŒ4.26ïŒïŒ®ïŒ3.53 å®æœäŸ ïŒ ïŒâïŒïŒâãã³ãŸã€ã«âïŒâãããããšãã«ïŒ
âïŒâã¡ãã«ãããã³äºé žãžãšãã«ãšã¹ãã« 50ïŒ æ°ŽçŽ åãããªãŠã ïŒæ²¹åæ£æ¶²0.6ïœïŒ0.012
ã¢ã«ïŒïŒç³æ²¹ãšãŒãã«ã§æŽæµãããã®ïŒããžã¡ã
ã«ãã«ã ã¢ãã10mlã«åæ£ãããã¹ã©ãªãŒã«ããž
ã¡ãã«ãã«ã ã¢ãã20mläžã®ïŒâïŒïŒâãã³ãŸã€
ã«âïŒâãããããšãã«ïŒãããã³äºé žãžãšãã«
ãšã¹ãã«3.6ïœïŒ0.009ã¢ã«ïŒã®æº¶æ¶²ã滎äžããã
ãã®æ··åç©ãïŒåéæ¹æããåŸããšãŠåã¡ãã«ïŒ
mlïŒ9.1ïœã0.065ã¢ã«ïŒãå ããåŸããã溶液ã
宀枩ã§ïŒæ©æ¹æããããã®æº¶æ¶²ãå·æ°Ž500mlã«æ
å ¥ããïŒæ©æŸçœ®ãããæ°Žå±€ãåŸã·ã€é€å»ããã¬ã
ç¶ã®æ®æž£ããžãšãã«ãšãŒãã«ã«æº¶è§£ããããã®ãš
ãŒãã«æº¶æ¶²ãæ°Žãšé£œåå¡©åãããªãŠã 溶液ã§æŽæµ
ããç¡«é žãããªãŠã ã§ä¹Ÿç¥ããæ¿çž®ããŠãç°è²åº
äœ3.5ïœïŒ95ïŒ ïŒãåŸããèç¹102ã104âïŒïŒâ
ãããããŒã«ããåçµæ¶åŸïŒã åæå€ïŒC21H21NO7 èšç®å€ïŒïŒ£ïŒ63.15ïŒïŒšïŒ5.30ïŒïŒ®ïŒ3.51 å®æž¬å€ïŒïŒ£ïŒ63.27ïŒïŒšïŒ5.34ïŒïŒ®ïŒ3.50 å®æœäŸ ïŒ ïŒâãã³ãŸã€ã«âïŒâããããã³ãŒã³é ¢é ž 20ïŒ ç¡«é ž50mlãšé ¢é ž50mlãšã«ïŒâïŒïŒâãã³ãŸ
ã€ã«âïŒâãããããšãã«ïŒãããã³äºé žãžãšã
ã«ãšã¹ãã«11.5ïœïŒ0.03ã¢ã«ïŒããšããã溶液ã
çªçŽ é°å²æ°äžã§ïŒæ©éæµå ç±ããããã®æº¶æ¶²ãæ¿
çž®ããæ®æž£ã2Néçé žã«ãªãŠã 450mlã§å¡©åºæ§ã«
ããããã®æ··åç©ããžãšãã«ãšãŒãã«ã§ïŒåæœåº
ããæ°Žå±€ãæ¿ç¡«é ž20mlã§é žæ§ã«ãããæåºããåº
äœãåããæ°ŽæŽããã€ãœãããããŒã«æ°Žæº¶æ¶²ã
ãåçµæ¶ããŠãè€è²åºäœ4.1ïœïŒ48ïŒ ïŒãåŸãã
èç¹160ã162âã åæå€ïŒC15H11NO5 èšç®å€ïŒïŒ£ïŒ63.16ïŒïŒšïŒ3.89ïŒïŒ®ïŒ4.91 å®æž¬å€ïŒïŒ£ïŒ63.15ïŒïŒšïŒ3.89ïŒïŒ®ïŒ4.90 å®æœäŸ ïŒ ïŒâïŒïŒâã¯ãããã³ãŸã€ã«ïŒâïŒâãããã
ã³ãŒã³é ¢é ž 20ïŒ ç¡«é ž40mlãšé ¢é ž40mlã«ïŒâãïŒâïŒïŒâã¯
ãããã³ãŸã€ã«ïŒâïŒâãããããšãã«ãããã
ã³äºé žãžãšãã«ãšã¹ãã«6.9ïœïŒ0.017ã¢ã«ïŒããš
ããã溶液ãçªçŽ é°å²æ°äžã«ïŒæ©éæµå ç±ããã
åå¿æ··åç©ãå·åŽããæåºããåºäœãåããïŒ
ïŒ éçé žãããªãŠã 150mläžã§æ¹æããããã®æ··
åç©ãéãã液ãæ¿ç¡«é žã§é žæ§ã«ãããæåº
ããçœè²åºäœãåããã€ãœãããããŒã«æ°Žæº¶æ¶²
ããåçµæ¶ããŠã3.2ïœïŒ61ïŒ ïŒã®çœè²éç¶çµæ¶
ãåŸããèç¹164ã165âã åæå€ïŒC15H10ClNO5 èšç®å€ïŒïŒ£ïŒ56.35ïŒïŒšïŒ3.15ïŒïŒ®ïŒ4.38 å®æž¬å€ïŒïŒ£ïŒ56.56ïŒïŒšïŒ3.10ïŒïŒ®ïŒ4.52 å®æœäŸ ïŒ ïŒâãã³ãŸã€ã«âïŒâãããïŒÎ±âã¡ãã«ïŒã
ã³ãŒã³é ¢é ž ïŒâïŒïŒâãã³ãŸã€ã«âïŒâãããããšãã«ïŒ
âïŒâã¡ãã«ãããã³äºé žãžãšãã«ãšã¹ãã«3.0
ïœïŒ0.0075ã¢ã«ïŒãé ¢é ž20mlããã³20ïŒ ç¡«é ž20ml
ãããªãæ··åç©ãçªçŽ é°å²æ°äžã«ïŒæ©éæµå ç±ã
ããåŸãããé»ããã 溶液ãæ¿çž®ããæ®æž£ã2N
çé žã«ãªãŠã 200mlã§åŠçããããã®æ··åç©ããž
ãšãã«ãšãŒãã«ãšå ±ã«æ©ç ããéããŠãäžæº¶ç©
ãé€å»ããã液ãå±€åé¢ããæ°Žå±€ããžãšãã«ãš
ãŒãã«ã§æŽæµããããã®æ°Žæº¶æ¶²ã掻æ§çã§åŠç
ããã»ã©ã€ãã«ããéãã液ãæ¿æµé ž13mlã§
é žæ§ã«ãããæåºããåºäœãåããïŒâããã
ããŒã«æ°Žæº¶æ¶²ããåçµæ¶ããŠã0.4ïœïŒ18ïŒ ïŒã®
çœè²ç²æ«ãåŸããèç¹177ã179âã åæå€ïŒC16H13NO3 èšç®å€ïŒïŒ£ïŒ64.21ïŒïŒšïŒ4.38ïŒïŒ®ïŒ4.61 å®æž¬å€ïŒïŒ£ïŒ64.43ïŒïŒšïŒ4.44ïŒïŒ®ïŒ4.71 å®æœäŸ ïŒ ïŒâãã³ãŸã€ã«âïŒâãããããšãã«ã¢ã»ãã¢
ãã ïŒâãã³ãŸã€ã«âïŒâããããã³ãŒã³é ¢é ž8.1
ïœïŒ0.028ã¢ã«ïŒãå¡©åããªãã«50mlããã³ãã³ãŒ
ã³50mlãããªãæ··åç©ãïŒæ©éæµå ç±ãããåŸã
ããé»ããã 溶液ãæ¿çž®ããæ®æž£ããã³ãŒã³ã§ïŒ
åæŽã€ãŠã8.1ïœïŒ94ïŒ ïŒã®é žå¡©åç©ãæ²¹ç¶ç©ãš
ããŠåŸãããã®é žå¡©åç©4.0ïœïŒ0.013ã¢ã«ïŒãã
ãã©ããããã©ã³20mlã«ãšããã溶液ããæ¿ãã
æ¹æããªããæ¿æ°Žé žåã¢ã³ã¢ããŠã 50mlã«å ã
ãããã®æ··åç©ã宀枩ã§ïŒæéæ¹æããåŸãå·æ°Ž
200mlãå ãããæ··åç©ãå75mlã®ãžãšãã«ãšãŒ
ãã«ã§ïŒåæœåºããåããããžãšãã«ãšãŒãã«æœ
åºæ¶²ãæ°ŽæŽããç¡«é žãããªãŠã ã§ä¹Ÿç¥ããæ¿çž®ã
ãŠãç²è£œã®ã¢ãããã¬ã ç¶ã§åŸãããã®ç²è£œç©ã¯
ïŒæ©æŸçœ®ãããšçµæ¶åããããã®åºäœããã³ãŒã³
ããåçµæ¶ããŠã14ïœïŒ38ïŒ ïŒã®çæç©ãåŸãã
èç¹137ã139âïŒå解ïŒã åæå€ïŒC15H12N2O4 èšç®å€ïŒïŒ£ïŒ63.38ïŒïŒšïŒ4.26ïŒïŒ®ïŒ9.85 å®æž¬å€ïŒïŒ£ïŒ63.24ïŒïŒšïŒ4.17ïŒïŒ®ïŒ9.72 å®æœäŸ ïŒ ïŒâãã³ãŸã€ã«âïŒâãããããšãã«é ¢é žãšã
ã« ïŒâãã³ãŸã€ã«âïŒâããããã³ãŒã³é ¢é žã®é ž
å¡©åç©ãå®æœäŸïŒãšåæ§ã«èª¿è£œãããTHF10ml
äžã®åŸãããé žå¡©åç©2.0ïœïŒ0.006ã¢ã«ïŒã®æº¶æ¶²
ããç¡æ°Žãšãã«ã¢ã«ã³ãŒã«50mlããã³ããªãšãã«
ã¢ãã³ïŒmlã§åŠçããããã®æ··åç©ã宀枩ã§ïŒæ
éæ¹æããæ¿çž®ããæ®æž£ãå¡©åã¡ãã¬ã³ãšæ°Žãšã®
éã§åé ãããå¡©åã¡ãã¬ã³å±€ãç¡«é žãããªãŠã
ã§ä¹Ÿç¥ããæ¿çž®ããŠãé»ããã ã¬ã ç¶ã®æ®æž£ãåŸ
ãããã®æ®æž£ããžãšãã«ãšãŒãã«ã«æº¶è§£ããé
ããŠãé»ããã äžæº¶æ§ã®äžçŽç©ãé€å»ããã液
ãæ¿çž®ããŠãã¬ã ç¶ã®æ®æž£ãåŸãããã®æ®æž£ã¯ïŒ
é±éã®æŸçœ®åŸã«æçµçã«ã¯çµæ¶åããããã®åºäœ
ãã€ãœãããã«ã¢ã«ã³ãŒã«ããïŒååçµæ¶ãïŒæŽ»
æ§çåŠçã䜵çšïŒã0.4ïœïŒ19ïŒ ïŒã®æ·¡é»è²ç²æ«ã
åŸããèç¹83ã85âã åæå€ïŒC17H15NO5 èšç®å€ïŒïŒ£ïŒ65.17ïŒïŒšïŒ4.83ïŒïŒ®ïŒ4.47 å®æž¬å€ïŒïŒ£ïŒ65.05ïŒïŒšïŒ4.83ïŒïŒ®ïŒ4.46 åèäŸ ïŒ å®æœäŸïŒã®æ¹æ³ã«ãããã€ãŠããã ãïŒïŒâã¯
ããâïŒâãããããšãã«ïŒïŒïŒâã¯ããããš
ãã«ïŒã¡ã¿ãã³ã«ä»£ããŠçã¢ã«éã®äžèšåå
ç©ïŒ ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒïŒïŒ
âãžã¯ããããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒâã¡
ãã«ããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒâã¡
ããã·ããšãã«ïŒã¡ã¿ãã³ãããã³ ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒâã
ããããšãã«ïŒã¡ã¿ãã³ã ã䜿çšãããšãäžèšçæç©ïŒ ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãããã³ãŸã€ã«ïŒâ
ïŒâãããããšãã«ããããã³äºé žãžãšãã«ãšã¹
ãã«ã ïŒâãïŒâïŒïŒâã¡ãã«ãã³ãŸã€ã«ïŒâïŒâã
ããããšãã«ããããã³äºé žãžãšãã«ãšã¹ãã«ã ïŒâãïŒâïŒïŒâã¡ããã·ãã³ãŸã€ã«ïŒâïŒâ
ãããããšãã«ããããã³äºé žãžãšãã«ãšã¹ã
ã«ã ããã³ ïŒâãïŒâïŒïŒâããããã³ãŸã€ã«ïŒâïŒâã
ããããšãã«ããããã³äºé žãžãšãã«ãšã¹ãã«ã ãåŸãããã åèäŸ ïŒ å®æœäŸïŒã®æ¹æ³ã«ãããã€ãŠããã ãïŒâïŒïŒ
âãã³ãŸã€ã«âïŒâãããããšãã«ïŒãããã³
äºé žã«ä»£ããŠçã¢ã«éã®äžèšååç©ïŒ ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãããã³ãŸã€ã«ïŒâ
ïŒâãããããšãã«ããããã³äºé žãžãšãã«ãšã¹
ãã«ã ïŒâãïŒâïŒïŒâã¡ãã«ãã³ãŸã€ã«ïŒâïŒâã
ããããšãã«ããããã³äºé žãžãšãã«ãšã¹ãã«ã ïŒâãïŒâïŒïŒâã¡ããã·ãã³ãŸã€ã«ïŒâïŒâ
ãããããšãã«ããããã³äºé žãžãšãã«ãšã¹ã
ã«ã ããã³ ïŒâãïŒâïŒïŒâããããã³ãŸã€ã«ïŒâïŒâã
ããããšãã«ããããã³äºé žãžãšãã«ãšã¹ãã«ã ã䜿çšãããšãäžèšçæç©ïŒ ïŒâïŒïŒïŒïŒâãžã¯ãããã³ãŸã€ã«ïŒâïŒâã
ãããã³ãŒã³é ¢é žã ïŒâïŒïŒâã¡ãã«ãã³ãŸã€ã«ïŒâïŒâãããã
ã³ãŒã³é ¢é žã ïŒâïŒïŒâã¡ããã·ãã³ãŸã€ã«ïŒâïŒâããã
ãã³ãŒã³é ¢é žãããã³ ïŒâïŒïŒâããããã³ãŸã€ã«ïŒâïŒâãããã
ã³ãŒã³é ¢é žã ãåŸãããã æ¬çºæã¯ãæ¬çºæã®ååç©ãæå¹æåãšããŠå«
æããæ°èŠãªæ²»ççšçµæç©ãå å«ãããååºã®è¬
çåŠçã«æŽ»æ§ãªä»»æã®ååç©ã®æå¹éããåçš®ã®
çµè·¯ãããããšãã°ã«ãã»ã«å€ãããã¯é å€ã®åœ¢
æ ã§ã®çµå£æäžãæ» è溶液ãããã¯æžæ¿æ¶²ã®åœ¢æ
ã§ã®éçµå£æäžãæãã¯å Žåã«ãã€ãŠã¯æ» è溶液
ã®åœ¢æ ã§ã®æ³šèå æäžã«ããæäžã§ãããæ¬çºæ
ã®æ°èŠååç©ã®åœ¢æã«ããã€ãŠã¯ãæå¹æåãé©
åœãªæ äœãäžè¬çã«ã¯è£œå€çšæ äœã«æ··å ¥ãããæ¬
çºæã®çµæç©ã®èª¿è£œã«æçšãªå¥œé©ãªè£œå€çšæ äœã®
äŸãšããŠã¯ãã§ãã·ãããŒã©ãã³ããããŠç³ïŒã°
ã«ã³ãŒã¹ïŒãçé žãã°ãã·ãŠã ãä¹³ç³ã麊èœãªã©
ãæããããã液äœçµæç©ãæ¬çºæã®ç¯å²å ã§ã
ã€ãŠã奜é©ãªæ¶²ç¶ã®è£œå€çšæ äœã«ã¯ãšãã«ã¢ã«ã³
ãŒã«ããããã¬ã³ã°ãªã³ãŒã«ãã°ãªã»ãªã³ããã
ãŠç³ã·ããããªã©ãããã æ¬çºæã®è¬çåŠç掻æ§ååç©ã¯ãæäžãã人ã
ããã¯åç©ã®äœéã«å¿ããŠ0.1ã250mgæãã¯ãã
以äžã®åäœçšéã§æå©ã«äœ¿çšããããããšãã°ã
銬ã®ãããªå€§ååç©ã¯æå¹æå500ã1000mgã®é
å€ãå¿ èŠãšãããããã®ãããªåäœçšéã¯ïŒæ¥ã«
é©åœãªåæ°ã ãæäžãããããããã€ãŠãæ¥çšé
ã¯0.3ã450mgã®ç¯å²å ãšãªãããšãå€ããïŒåã®
æäžã«ã€ãïŒã25mgãæé©ã§ãããšæãããã å¯äžã®å¿ èŠãªæ¡ä»¶ã¯ãæå¹æåãæå¹éã ãå
åšãããããªãã¡ã䜿çšããå€åœ¢ãšççŸããã«é©
åœãªæå¹çšéãåŸãããããã«ãããšããããšã§
ãããåã ã®å ·äœäŸã§ã®å³å¯ãªçšéããã³æ¥çšé
ã¯ããã¡ããå»åž«ãŸãã¯ç£å»ã®æ瀺ã®ããšã«æšæº
çãªå»åŠåçã«ãããã€ãŠæ±ºå®ããããã æ¬çºæã®æå¹è¬å€ã¯ãä»ã®è¬çåŠçã«æŽ»æ§ãªè¬
å€æãã¯ç·©è¡å€ãå¶é žå€ãªã©ãšçµã¿åãããŠæäž
ããããšãã§ããçµæç©äžã®æ¬çºæã®æå¹è¬å€ã®
å²åã¯åºç¯å²ã«ãããã 以äžã«ãæ¬çºæã®çµæç©ã®å ·äœäŸãäŸç€ºããã (1) ã«ãã»ã«å€ ïŒã«ãã»ã«ã«ã€ãæå¹æåïŒmgã25mgãããã³
50mgã®ã«ãã»ã«å€ã調補ããããæå¹æåã®éã
å€ãå Žåã«ã¯ãä¹³ç³ã®éã§èª¿æŽããããšãã§ã
ãã ãè¡šã å¥ã®ã«ãã»ã«çšçµæç©ãšããŠãããå€éã®æå¹
æåãå«æããã®ã«é©ããçµæç©ã®äŸã次ã«ç€º
ãã ãè¡šã ãããã®å Žåãã䜿çšããæå¹æåãä¹³ç³ãã§
ãã·ãããã³ã¹ãã¢ãªã³é žãã°ãã·ãŠã ãšåäžã«
æ··åããæ··åç©ãã«ãã»ã«ã«å å¡«ããã (2) é å€ ïŒé å€åœã5.0mgã®æå¹æåãå«æããé å€çš
ã®ä»£è¡šçãªçµæç©ã次ã«ç€ºãããã®çµæã¯ããªã³
é žäºã«ã«ã·ãŠã ã®éã調æŽããããšã«ããæå¹æ
åã®å䟡ãç°ãªãå Žåã«ãå¿çšã§ããã ïŒé åœãïŒmgïŒ (a) æå¹æå 5.0 (b) ã³ãŒã³ã¹ã¿ãŒã 13.6 (c) ã³ãŒã³ã¹ã¿ãŒãïŒããŒã¹ãïŒ 3.4 (d) ä¹³ç³ 79.2 (e) ãªã³é žäºã«ã«ã·ãŠã 68.0 (f) ã¹ãã¢ãªã³é žã«ã«ã·ãŠã 0.9 170.1mg (a)ã(b)ã(d)ããã³(e)ãåäžã«æ··åããã(c)ã10
ïŒ æ°Žæ§ããŒã¹ããšããŠèª¿è£œãããäžèšæ··åç©ãã§
ãã·ãããŒã¹ããšå ±ã«é¡ç²åãã湿ã€ãé¡ç²ãïŒ
ã¡ãã·ãŠã®ãµããã«éãã湿ã€ãé¡ç²ã也ç¥ãã
ãåŸã12ã¡ãã·ãŠã®ãµããã«éããŠç²åºŠãããã
ãã也ç¥ããé¡ç²ãã¹ãã¢ãªã³é žã«ã«ã·ãŠã ãšæ··
åããæé ããã (3) ïŒïŒ æ» è泚å°æ¶² ïŒc.c.åœã æå¹æå 20mg é²è å€ïŒäŸãã¯ãããã¿ããŒã«ïŒ 0.5WïŒïŒ¶ïŒ 泚å°çšèžçæ°Žãå ã㊠ïŒc.c. äžèšçµæã®æº¶æ¶²ã調補ããéã«ããæž æŸåã
ãåŸãã¬ã©ã¹ã³ãã«å å¡«ããå¯å°ããå§ç±æ» èã
ãã 以äžã«æ¬çºæã詳述ããããåçš®ã®å€æŽãªãã³
ã«åçç©ããã³åçæ段ãåœæ¥è ã«ã¯æããã§ã
ã€ãŠãæ¬çºæã®ç¯å²ãéžè±ããã«æ¬çºæã®åå
ç©ãçµæç©ããã³æ¹æ³ã«ãããŠå®æœã§ããããšã¯
ç解ããããã
ãããããšãã«é ¢é žããã³èªå°äœïŒéå±å¡©ãã¢ã
ãããã³ãšã¹ãã«é¡ïŒãããããçšããæ²»çæ³ã
è¬å€çµæç©ããã³ãã®çšéããªãã³ã«ãããã®å
åç©ããã³æ°èŠäžéäœã®è£œé æ³ã«é¢ãããæ¬çºæ
ã®ïŒâãã³ãŸã€ã«âïŒâãããããšãã«é ¢é žãã
ã³èªå°äœã¯ãåç©çäœãžã®å çšã«ãããæãŸãã
ãªãå¯äœçšãæå°éãããªãæ¶çå€ã§ããã æççäœçšãæããïŒâã¢ããâïŒâãã³ãŸã€
ã«ããšãã«é ¢é žãªãã³ã«ãã®ãšã¹ãã«ããã³éå±
å¡©ã¯ç±³åœç¹èš±4045576ã«é瀺ãããŠããã æ¬çºæã®ååç©ã®ç°æ§äœã§ããïŒâãã³ãŸã€ã«
âïŒâãããããšãã«é ¢é žã¯BeilsteinïŒææ©å
åŠ10ã361ïŒ1910â1919ïŒã«å ±åãããŠããã å¥ã®ç°æ§äœã§ããïŒâãã³ãŸã€ã«âïŒâããã
ããšãã«âïŒâããããªã³é žã¯ãFenic et al.J.
Het.Chem.14ã1225ïŒ1977ïŒã®ãã³ãŸãžã¢ãŒãã³
ã®è£œé ã«ãããäžéäœãšããŠå ±åãããŠããã åŸæ¥ã匷åãªæççè¬å€ã¯ãæå¹ç¯å²å ã®éã§
人ããã³åç©ã«çµå£æäžãããšãã«äžè¬ã«èã®åº
è¡ããã³æœ°ç圢æãšããé倧ãªå¯äœçšãçããã
ãšãèªããããŠãããæ¬çºæã®ååç©ã¯ãççã
ç·©åããããã«æå¹ç¯å²å ã®éã§æäžããå Žåã«
èªããããèã®åºæ¿ã®çºççããã€ã³ãã¡ã¿ã·ã³
ããã³ç±³åœç¹èš±4045576ã«é瀺ãããïŒâã¢ãã
âïŒâãã³ãŸã€ã«ããšãã«é ¢é žã«æ¯ã¹ãŠäœããšã
ãå©ç¹ãæããããšãå€æããã æççäœçšã瀺ãæ¬çºæã®æ°èŠååç©ã¯ãäžè¬
ã«äžèšäžè¬åŒã§ç€ºãããïŒâãã³ãŸã€ã«âïŒâ
ãããããšãã«é ¢é žãéå±å¡©ãã¢ããããã³ãšã¹
ãã«é¡ã§ããã äžèšåŒäžã R1ã¯æ°ŽçŽ ãŸãã¯äœçŽã¢ã«ãã«ã R2ã¯OHãOMãâäœçŽã¢ã«ãã«ãNH2ã
NHâäœçŽã¢ã«ãã«ãŸãã¯âïŒïŒ®âãžäœçŽã¢ã«
ãã«ã ã¯æ°ŽçŽ ãŸãã¯ããã²ã³ã ïŒã¯å»è¬ãšããŠèš±å®¹ãããã«ããªã³ãããã¯å€
䟡ã«ããªã³ã®å Žåã¯ã«ããªã³ã®äžéšåããŸãã¯ã
ã®æ°Žåç©ã ïœã¯ïŒãïŒã®æŽæ°ãããããæå³ããã æ¬çºæã«ããæäŸãããå¥ã®æ°èŠååç©ã¯ãæ¬
çºæã®äžèšæççæ§ååç©ã®è£œé çšäžéäœã§ãã
äžèšäžè¬åŒã§ç€ºãããïŒâïŒïŒâãã³ãŸã€ã«â
ïŒâãããããšãã«ïŒã¢ã«ã«ã³äºé žãžã¢ã«ãã«ãš
ã¹ãã«ã§ããã äžèšåŒäžãR1ãšïŒžã¯åèšå®çŸ©ã®ãšããã§ããã äžè¬åŒã®ååç©ãšããŠã¯ãäœçŽã¢ã«ãã«ããš
ãã«ã§ããååç©ã奜ãŸããã æ¬æ现æžã«ãããäžè¬åŒã§çšããèšå·ã®å®çŸ©ã«
ãããŠã䜿çšãããŠããåçšèªã®æå³ã¯æ¬¡ã®ãšã
ãã§ããã ãäœçŽã¢ã«ãã«ããšã¯ãççŽ æ°ïŒãŸã§ã®çŽéã
ãã³åå²éã®åºãå å«ãããã®äŸãšããŠã¯ã¡ã
ã«ããšãã«ããããã«ãã€ãœãããã«ãããã«ã
secâããã«ãtertâããã«ãã¢ãã«ãã€ãœã¢ã
ã«ãããã·ã«ããããã«ããã³ãªã¯ãã«ãªã©ã®åº
ãæããããããäœçŽã¢ã«ã³ãã·ããšã¯ãåŒâ
âäœçŽã¢ã«ãã«ã§ç€ºãããåºã§ããã æ¬æ现æžã§èšåããå Žåã®ãããã²ã³ããšã¯ã
ããçŽ ãå¡©çŽ ãèçŽ ããã³ãšãŠçŽ ã奜ãŸããã¯ã
ãçŽ ãå¡©çŽ ããã³èçŽ ãå å«ããã æ¬æ现æžã§èšåããå Žåã®é žã®å¡©ã圢æãã
ãå»è¬ãšããŠèš±å®¹ãããã«ããªã³ãããã³ãã®æ°Ž
åç©ãšã¯ãããšãã°ãããªãŠã ãã«ãªãŠã ãã«ã«
ã·ãŠã ããã°ãã·ãŠã ãäºéãé ããã³ã¢ã«ãã
ãŠã ãªã©ã®ä»»æã®å»è¬ãšããŠèš±å®¹ãããéå±ã«ã
ãªã³ãªãã³ã«æ°Žåæ°Žãå å«ããããããªãŠã ã«ã
ãªã³ã奜ãŸããã æçç掻æ§ã¯ã(1)L.F.SancilioãJ.Pharmacol.
Exp.Ther.168ïŒ199â204ïŒ1969ïŒã«èšèŒã®ãšãã³
ã¹éã«ã©ãžãŒãã³èžè滲åºæ¶²åææ³ã®å€æ³ã(2)
Walz et alïŒJ.Pharmacol.Exp.Ther.178ïŒ223â
231ã«èšèŒã®ã©ããã«ãããè£å©è¬èªçºé¢ç¯çæ³ã
ããã³(3)Winter et alïŒProc.Soc.Exp.Biol.Med.
111ïŒ544â547ïŒ1962ïŒã«èšèŒã®ã«ã©ãžãŒãã³èªçº
è¶³æµ®è «æ³ãçšããŠå®éšåç©ã«ãããŠå®èšŒãããã äžèšã®èžè滲åºæ¶²åææ³ã§ã€ã³ãã¡ã¿ã·ã³ãšæ¯
èŒè©Šéšããå Žåãæ¬çºæã®ååç©ã¯äžè¬ã«ã€ã³ã
ã¡ã¿ã·ã³ããå¹åãããäœãããèãžã®åºæ¿ã¯ã€
ã³ãã¡ã¿ã·ã³ã§èªãããããã®ã®ã»ãã®ããäžéš
ãã瀺ããªãã€ãã äžã§è¿°ã¹ãç°æ§äœïŒâãã³ãŸã€ã«âïŒâããã
ããšãã«é ¢é žã補é ããè©Šéšãããšããããšãã³
ã¹éã«ã©ãžâãã³èžè滲åºåææ³ã«ãããŠ100
mgïŒKgã§ãæçç掻æ§ããŸã€ããæããŠããªãã
ãšãå€æãããããã«å¯ŸããŠãåŸåºã®å®æœäŸïŒã®
ååç©ã¯ïŒmgïŒKgã§åŒ·ã掻æ§ã瀺ããã ãã€ãŠãæ¬çºæã®ç®çã¯æ°èŠãªïŒâãã³ãŸã€ã«
âïŒâãããããšãã«é ¢é žããã®å¡©ããã³æ°Žå
ç©ãã¢ãããªãã³ã«ãšã¹ãã«é¡ãæäŸããããšã§
ããã å¥ã®ç®çã¯ãïŒâãã³ãŸã€ã«âïŒâãããããš
ãã«é ¢é žããã®ã¢ããããã³ãšã¹ãã«ãçšããã
èè žéšãžã®æãŸãããªãå¯äœçšãæå°éã«æããŠ
ççãç·©åããããã®çäœãç¹ã«äººãå«ãåºä¹³å
ç©ã®çäœã®æ°èŠãªæ²»çæ³ããªãã³ã«ãã®ããã®æ²»
ççšçµæç©ãæäŸããããšã§ããã æ¬çºæã®ãŸãå¥ã®ç®çã¯æ°èŠãªäžéäœãæäŸã
ãããšã§ããã ããã«å¥ã®ç®çãåœæ¥è ã«ã¯æããã§ãããã
ã®ä»ã®ç®çã¯ä»¥äžã®èšèŒããæãããšãªããã äžèšäžè¬åŒã®äžéäœã¯äžèšã®åå¿åŒã«ããã
ã€ãŠè£œé ãããïŒ ïŒåŒäžããšïœã¯åèšå®çŸ©ã®ãšããïŒãäžè¬åŒ
ïœãšïœã¯äžè¬åŒã«å å«ãããã R2ãOHãŸãã¯OMã§ããäžè¬åŒã®ïŒâãã³
ãŸã€ã«âïŒâãããããšãã«é ¢é žãšéå±å¡©ã¯ãäž
èšã®åå¿åŒã«ãããã€ãŠè£œé ãããïŒ ïŒåŒäžãR1ïŒïŒžïŒïœããã³ïŒã¯åèšå®çŸ©ã®ãš
ããïŒã éé¢ã®ïŒâãã³ãŸã€ã«âïŒâãããããšãã«é ¢
é žã¯ãäžèšã®åå¿åŒã«ãããã€ãŠãã¢ããïŒR2
ïŒNH2ïŒãäœçŽã¢ã«ãã«ã¢ããïŒR2ïŒNHâäœçŽ
ã¢ã«ãã«ïŒããžäœçŽã¢ã«ãã«ã¢ãããR2ïŒïŒ®â
ïŒäœçŽã¢ã«ãã«ïŒ2ãããã³ãšã¹ãã«ïŒR2ïŒïŒ¯âäœ
çŽã¢ã«ãã«ïŒã«è»¢åãããããšãã§ããïŒ ïŒåŒäžãR1ïŒïŒžããã³ïœã¯åèšå®çŸ©ã®ãšã
ãïŒãäžè¬åŒïœãªããïœã¯ããããäžè¬åŒ
ã«å å«ãããã æ¬çºæã®ïŒâãã³ãŸã€ã«âïŒâãããããšãã«
é ¢é žã補é ããã®ã«çšããããäžèšäžè¬åŒã®åº
çºç©è³ªã¯æ¬¡ã®åå¿åŒã§ç€ºãæ¹æ³ã«ãã補é ã§ã
ãïŒ ïŒåŒäžããšïœã¯åèšå®çŸ©ã®ãšããïŒã åºçºç©è³ªããã³ã®è£œé æ³ã¯äžèšã®è£œé äŸã«
ãã詳ãã説æãããŠããã 補é äŸ ïŒ ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒããšãã«
ã¡ã¿ãã³ ïŒïŒïŒïŒïŒïŒïŒâããã©ã¯ãããšã¿ã³200mläž
ã®ïŒâã¯ããã¢ããªã³36.1ïœïŒ0.30ã¢ã«ïŒã®å·æº¶
液ã«ãäžå¡©åããŠçŽ 34.0ïœïŒ0.33ã¢ã«ïŒã®ããã©
ã¯ãããšã¿ã³ïŒ150mlïŒå·æº¶æ¶²ããã³ãŸãããªã«
60mlïŒ0.6ã¢ã«ïŒããã³äžå¡©åã¢ã«ãããŠã 44.0
ïœïŒ0.33ã¢ã«ïŒãé ã«å ãããåŸããã溶液ãïŒ
æééæµå ç±ããå·åŽåŸã«2Nå¡©é ž200mlã§åŠç
ããããã«0.5æéèžæ°æµŽå ç±ãããçžåé¢ãã
åŸãææ©å±€ãç¡«é žãããªãŠã ã§ä¹Ÿç¥ããæ¿çž®ã
ããæ®æž£ã100âããã³0.2mmïœã§ç空èžçã
ããã«ãæ®ãã·ãªã«ã²ã«250ïœã§ã¯ãããã°ã©ã
åŠçããŠã43.6ïœïŒ63ïŒ ïŒã®é»è²ç²æ«ãåŸããè
ç¹54ã56âïŒãªã°ãã€ã³ããåçµæ¶åŸïŒã åæå€ïŒC13H10ClNO èšç®å€ïŒïŒ£ïŒ67.40ïŒïŒšïŒ4.35ïŒïŒ®ïŒ6.05 å®æž¬å€ïŒïŒ£ïŒ67.41ïŒïŒšïŒ4.35ïŒïŒ®ïŒ6.06 補é äŸ ïŒ ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒâã¯
ããããšãã«ïŒã¡ã¿ãã³ ïŒïŒïŒïŒïŒïŒïŒâããã©ã¯ãããšã¿ã³100mläž
ã®ïŒâã¯ããã¢ããªã³44.4ïœïŒ0.35ã¢ã«ïŒã®å·æº¶
液ã«ãããã©ã¯ãããšã¿ã³100mläžã®äžå¡©åããŠ
çŽ 44.6ïœïŒ0.38ã¢ã«ïŒã®æº¶æ¶²ã次ãã§ããã©ã¯ã
ããšã¿ã³225mläžã®ïŒâã¯ãããã³ãŸãããªã«100
ïœïŒ0.73ã¢ã«ïŒã®æº¶æ¶²ããã³äžå¡©åã¢ã«ãããŠã
50.5ïœïŒ0.38ã¢ã«ïŒãå ãããåŸããã溶液ãïŒ
æééæµå ç±ããåŸãå·åŽãã2Nå¡©é ž240mlã§åŠ
çããããã«0.5æéèžæ°æµŽå ç±ãããåå¿æ··å
ç©ãå·åŽããã»ã©ã€ãã§éããã液ãçžåé¢
ããææ©å±€ãæ¿çž®ãããæ®æž£ã100âããã³02mm
ïœã§ç空èžçãããã«ãæ®ïŒ105ïœïŒã400ïœã®
ã·ãªã«ã²ã«ã§ã¯ãããã°ã©ãåŠçããŠã58.4ïœã®
æ²¹ç¶ç©ãåŸããããã¯çµæ¶åãããåŸãããåºäœ
ãã€ãœãããã«ã¢ã«ã³ãŒã«ããïŒååçµæ¶ããŠã
33.0ïœïŒ35ïŒ ïŒã®é»è²éç¶çµæ¶ãåŸããèç¹85
âã åæå€ïŒC13H9Cl2NO èšç®å€ïŒïŒ£ïŒ58.67ïŒïŒšïŒ3.41ïŒïŒ®ïŒ5.26 å®æž¬å€ïŒïŒ£ïŒ58.73ïŒïŒšïŒ3.38ïŒïŒ®ïŒ5.31 補é äŸ ïŒ ïŒïŒâã¯ããâïŒâãããããšãã«ïŒããšãã«
ã¡ã¿ãã³ 90ïŒ éé žåæ°ŽçŽ 10.8mlãšå¡©åã¡ãã¬ã³250mlã
ããªãå·åŽã»æ¹æãããæ··åç©ã«ãç¡æ°Žããªãã«
ãªãé ¢é ž100ïœïŒ67.6mlïŒã45åéãããŠæ»Žäžã
ãã氷济ãåãã¯ãããå¡©åã¡ãã¬ã³100mläžã®
ç²è£œïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒããšã
ã«ã¡ã¿ãã³23.1ïœïŒ0.1ã¢ã«ïŒã®æº¶æ¶²ã45åéã
ããŠæ»ŽäžãããåŸãããé»ããã 溶液ãïŒæéèž
æ°æµŽå ç±ããåŸãå·åŽããå·æ°Žå200mlã§ïŒåã
å·10ïŒ çé žãããªãŠã ïŒä¹³æ¿æ¶²ïŒå200mlã§ïŒå
ããã³é£œåå¡©åãããªãŠã 溶液ã§ïŒåã®é ã«æŽæµ
ãããæŽæµåŸã®å¡©åã¡ãã¬ã³æº¶æ¶²ãç¡«é žãããªãŠ
ã ã§ä¹Ÿç¥ããæ¿çž®ããŠã19.6ïœã®æ²¹ç¶æ®æž£ãåŸ
ãããã®æ²¹ç¶ç©ã250ïœã®ã·ãªã«ã²ã«ã§ã¯ããã
ã°ã©ãåŠçããŠã15.3ïœïŒ59ïŒ ïŒã®æ²¹ç¶ç©ãåŸ
ãããã®çæç©ã¯ãåšå£ã®ãããã«ããçµæ¶åã
ãããã®åºäœãã€ãœãããããŒã«ããåçµæ¶ã
ãŠãé»è€è²ã®åºäœãåŸãã èç¹67ã69âã åæå€ïŒC13H8ClNO3 èšç®å€ïŒïŒ£ïŒ59.67ïŒïŒšïŒ3.08ïŒïŒ®ïŒ5.35 å®æž¬å€ïŒïŒ£ïŒ59.78ïŒïŒšïŒ3.06ïŒïŒ®ïŒ5.35 補é äŸ ïŒ ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒâã¯
ããããšãã«ïŒã¡ã¿ãã³ 90ïŒ éé žåæ°ŽçŽ 10.0mlãšå¡©åã¡ãã¬ã³250mlãš
ã®å·åŽã»æ¹æãããæ··åç©ã«ãç¡æ°Žããªãã«ãªã
é ¢é ž100ïœãïŒæéãããŠæ»Žäžããã氷济ãåã
ã¯ãããå¡©åã¡ãã¬ã³100mläžã®ïŒïŒâã¢ããâ
ïŒâã¯ããããšãã«ïŒïŒïŒâã¯ããããšãã«ïŒã¡
ã¿ãã³26.6ïœïŒ0.10ã¢ã«ïŒã®æº¶æ¶²ãïŒæéãããŠ
滎äžãããåŸãããé»ããã 溶液ãïŒæéèžæ°æµŽ
å ç±ããå·åŽããé ã«å·æ°Žå200mlã§ïŒåãå·10
ïŒ çé žãããªãŠã å200mlã§ïŒåããã³é£œåå¡©å
ãããªãŠã 溶液ã§ïŒåæŽæµãããæŽæµããå¡©åã¡
ãã¬ã³å±€ãç¡«é žãããªãŠã ã§ä¹Ÿç¥ããæ¿çž®ããŠã
é»è€è²åºäœ19.9ïœãæ®æž£ãšããŠåŸãããã®åºäœã
ã·ãªã«ã²ã«400ïœã§ã¯ãããã°ã©ãåŠçããŠãç®
çãšããçæç©11.9ïœïŒ40ïŒ ïŒãåŸããäžéšãã¢
ã»ããããªã«ããïŒåãç¡æ°Žãšã¿ããŒã«ããïŒå
åçµæ¶ãããšãèç¹147ã148âã®åæçšè©Šæãçœ
è²åºäœãšããŠåŸãããã åæå€ïŒC13H7Cl2NO3 èšç®å€ïŒïŒ£ïŒ52.73ïŒïŒšïŒ2.38ïŒïŒ®ïŒ4.73 å®æž¬å€ïŒïŒ£ïŒ53.11ïŒïŒšïŒ2.38ïŒïŒ®ïŒ4.85 補é äŸ ïŒ è£œé äŸïŒã®æ¹æ³ã«ãããã€ãŠããã ãïŒâã¯ã
ããã³ãŸãããªã«ã«ä»£ããŠçã¢ã«éã®äžèšåå
ç©ïŒ ïŒïŒïŒâãžã¯ããããšãã«ã¡ã¿ãã³ã ïŒâã¡ãã«ããšãã«ã¡ã¿ãã³ã ïŒâã¡ããã·ããšãã«ã¡ã¿ãã³ãããã³ ïŒâãããããšãã«ã¡ã¿ãã³ã ã䜿çšãããšãäžèšçæç© ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒïŒïŒ
âãžã¯ããããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒâã¡
ãã«ããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒâã¡
ããã·ããšãã«ïŒã¡ã¿ãã³ãããã³ ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒâã
ããããšãã«ïŒã¡ã¿ãã³ã ãåŸãããã 補é äŸ ïŒ è£œé äŸïŒã®æ¹æ³ã«ãããã€ãŠããã ãïŒïŒâã¢
ããâïŒâã¯ããããšãã«ïŒïŒïŒâã¯ããããš
ãã«ïŒã¡ã¿ãã³ã«ä»£ããŠçã¢ã«éã®äžèšåå
ç©ïŒ ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒïŒïŒ
âãžã¯ããããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒâã¡
ãã«ããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒâã¡
ããã·ããšãã«ïŒã¡ã¿ãã³ãããã³ ïŒïŒâã¢ããâïŒâã¯ããããšãã«ïŒïŒïŒâã
ããããšãã«ïŒã¡ã¿ãã³ ã䜿çšãããšãäžèšçæç©ïŒ ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒïŒïŒ
âãžã¯ããããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒâã¡
ãã«ããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒâã¡
ããã·ããšãã«ïŒã¡ã¿ãã³ãããã³ ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒâã
ããããšãã«ïŒã¡ã¿ãã³ ãåŸãããã äžèšå補é äŸã«ãããŠã¯ãçæç©ãã¯ãããã°
ã©ãåŠçã«ããåé¢ãããããã®åé¢ã¯æ¬¡ã®ãã
ã«ããŠè¡ãªã€ãã溶åºïŒelutionïŒã¯åãã«ãã³
ãŒã³ãšãªã°ãã€ã³ïŒé«æ²žç¹ïŒ60â110âïŒç³æ²¹ãš
ãŒãã«ïŒãšã®æ··åç©ãçšããŠè¡ãªãã次ãã§çŽç²
ã®ãã³ãŒã³ãçšãçæç©ãã«ã©ã ããåé¢ããã æ¬çºæã®æ°èŠååç©ãšãã®è£œæ³ãäžèšã®å®æœäŸ
ã«ããããã«è©³ããäŸç€ºããããã ããæ¬çºæã®
ç¯å²ã¯ãããã«å¶éããããã®ã§ã¯ãªãã å®æœäŸ ïŒ ïŒâïŒïŒâãã³ãŸã€ã«âïŒâãããããšãã«ïŒ
ãããã³äºé žãžãšãã«ãšã¹ãã« ç³æ²¹ãšãŒãã«ã§æŽæµæžã¿ã®57ïŒ æ°ŽçŽ åãããªãŠ
ã ïŒæ²¹åæ£æ¶²1.9ïœïŒ0.044ã¢ã«ïŒãšä¹Ÿç¥ãžã¡ãã«
ã¹ã«ããã·ã25mlãšã®æ··åç©ã100âã«å ç±ãã
ãžã¡ãã«ã¹ã«ããã·ã25mläžã®ããã³é žãžãšãã«
7.0ïœïŒ0.044ã¢ã«ïŒã®æº¶æ¶²ã§åŠçããããã®æ··å
ç©ããåºåœ¢åããã¹ãŠæº¶è§£ããŠããŸããŸã§æ¹æã
ãåŸããžã¡ãã«ã¹ã«ããã·ã15mläžã®ïŒïŒâã¯ã
ãâïŒâãããããšãã«ïŒããšãã«ã¡ã¿ãã³5.4
ïœïŒ0.021ã¢ã«ïŒã®æº¶æ¶²ãå ãããåŸãããé»ã
ãã 溶液ã100âã«ïŒæéå ç±ããåŸã800mlã®æ°·
æ°Žäžã«æå ¥ããããã®æ··åç©ãå100mlã®ãã³ãŒ
ã³ã§ïŒåæœåºããåãããæœåºæ¶²ãæ°Žã§ïŒåã飜
åå¡©åãããªãŠã 溶液ã§ïŒåæŽæµããç¡«é žãããª
ãŠã ã§ä¹Ÿç¥ããæ¿çž®ããŠãåºäœæ®æž£ãåŸãããã®
åºäœãã€ãœãããããŒã«ããåçµæ¶ããŠã3.1ïœ
ïŒ46ïŒ ïŒã®çæç©ãåŸããèç¹130ã131âã åæå€ïŒC20H19NO7 èšç®å€ïŒïŒ£ïŒ62.34ïŒïŒšïŒ4.97ïŒïŒ®ïŒ3.64 å®æž¬å€ïŒïŒ£ïŒ62.31ïŒïŒšïŒ5.03ïŒïŒ®ïŒ3.60 å®æœäŸ ïŒ ïŒâãïŒâïŒïŒâã¯ãããã³ãŸã€ã«ïŒâïŒâã
ããããšãã«ããããã³äºé žãžãšãã«ãšã¹ãã« ç³æ²¹ãšãŒãã«ã§æŽæµæžã¿ã®50ïŒ æ°ŽçŽ åãããªãŠ
ã ïŒæ²¹åæ£æ¶²3.9ïœïŒ0.080ã¢ã«ïŒãšãžã¡ãã«ã¹ã«
ããã·ã50mlãšã®æ··åç©ã100âã«å ç±ãããžã¡
ãã«ã¹ã«ããã·ã15mläžã®ããã³é žãžãšãã«12.8
ïœïŒ0.080ã¢ã«ïŒã®æº¶æ¶²ã§åŠçãããåºäœåãã
ã¹ãŠæº¶è§£ãããŸã§æ··åç©ãæ¹æããåŸããžã¡ãã«
ã¹ã«ããã·ã35mläžã®ïŒïŒâã¯ããâïŒâããã
ããšãã«ïŒïŒïŒâã¯ããããšãã«ïŒã¡ã¿ãã³11.0
ïœïŒ0.037ã¢ã«ïŒã®æº¶æ¶²ãå ãããåŸãããé»ã
ãã 溶液ã90ã100âã«ïŒæéå ç±ããåŸãæ°ŽïŒ
ã«æå ¥ããïŒæ©æŸçœ®ãããåºäœïŒ5.5ïœïŒã
å¥ããã液ãïŒåãã³ãŒã³ã§æœåºãããåãã
ãæœåºæ¶²ãæ°Žãšé£œåå¡©åãããªãŠã 溶液ã§æŽæµ
ããç¡«é žãããªãŠã ã§ä¹Ÿç¥ããæ¿çž®ããŠãæ²¹ç¶æ®
枣ãåŸãããã®æ²¹ç¶ç©ãå°éã®ã€ãœãããã«ã¢ã«
ã³ãŒã«ã«æº¶è§£ããå ã«å¥ããåºäœã®äžéšãçš®æ¶
ãšããŠå ããŠçµæ¶åããããããã«3.1ïœã®çæ
ç©ãåŸãããåèšã®åºäœåéã¯8.6ïœïŒ55ïŒ ïŒãš
ãªã€ããèç¹96ã100âã åæå€ïŒC20H18ClNO7 èšç®å€ïŒïŒ£ïŒ57.22ïŒïŒšïŒ4.32ïŒïŒ®ïŒ3.34 å®æž¬å€ïŒïŒ£ïŒ57.19ïŒïŒšïŒ4.26ïŒïŒ®ïŒ3.53 å®æœäŸ ïŒ ïŒâïŒïŒâãã³ãŸã€ã«âïŒâãããããšãã«ïŒ
âïŒâã¡ãã«ãããã³äºé žãžãšãã«ãšã¹ãã« 50ïŒ æ°ŽçŽ åãããªãŠã ïŒæ²¹åæ£æ¶²0.6ïœïŒ0.012
ã¢ã«ïŒïŒç³æ²¹ãšãŒãã«ã§æŽæµãããã®ïŒããžã¡ã
ã«ãã«ã ã¢ãã10mlã«åæ£ãããã¹ã©ãªãŒã«ããž
ã¡ãã«ãã«ã ã¢ãã20mläžã®ïŒâïŒïŒâãã³ãŸã€
ã«âïŒâãããããšãã«ïŒãããã³äºé žãžãšãã«
ãšã¹ãã«3.6ïœïŒ0.009ã¢ã«ïŒã®æº¶æ¶²ã滎äžããã
ãã®æ··åç©ãïŒåéæ¹æããåŸããšãŠåã¡ãã«ïŒ
mlïŒ9.1ïœã0.065ã¢ã«ïŒãå ããåŸããã溶液ã
宀枩ã§ïŒæ©æ¹æããããã®æº¶æ¶²ãå·æ°Ž500mlã«æ
å ¥ããïŒæ©æŸçœ®ãããæ°Žå±€ãåŸã·ã€é€å»ããã¬ã
ç¶ã®æ®æž£ããžãšãã«ãšãŒãã«ã«æº¶è§£ããããã®ãš
ãŒãã«æº¶æ¶²ãæ°Žãšé£œåå¡©åãããªãŠã 溶液ã§æŽæµ
ããç¡«é žãããªãŠã ã§ä¹Ÿç¥ããæ¿çž®ããŠãç°è²åº
äœ3.5ïœïŒ95ïŒ ïŒãåŸããèç¹102ã104âïŒïŒâ
ãããããŒã«ããåçµæ¶åŸïŒã åæå€ïŒC21H21NO7 èšç®å€ïŒïŒ£ïŒ63.15ïŒïŒšïŒ5.30ïŒïŒ®ïŒ3.51 å®æž¬å€ïŒïŒ£ïŒ63.27ïŒïŒšïŒ5.34ïŒïŒ®ïŒ3.50 å®æœäŸ ïŒ ïŒâãã³ãŸã€ã«âïŒâããããã³ãŒã³é ¢é ž 20ïŒ ç¡«é ž50mlãšé ¢é ž50mlãšã«ïŒâïŒïŒâãã³ãŸ
ã€ã«âïŒâãããããšãã«ïŒãããã³äºé žãžãšã
ã«ãšã¹ãã«11.5ïœïŒ0.03ã¢ã«ïŒããšããã溶液ã
çªçŽ é°å²æ°äžã§ïŒæ©éæµå ç±ããããã®æº¶æ¶²ãæ¿
çž®ããæ®æž£ã2Néçé žã«ãªãŠã 450mlã§å¡©åºæ§ã«
ããããã®æ··åç©ããžãšãã«ãšãŒãã«ã§ïŒåæœåº
ããæ°Žå±€ãæ¿ç¡«é ž20mlã§é žæ§ã«ãããæåºããåº
äœãåããæ°ŽæŽããã€ãœãããããŒã«æ°Žæº¶æ¶²ã
ãåçµæ¶ããŠãè€è²åºäœ4.1ïœïŒ48ïŒ ïŒãåŸãã
èç¹160ã162âã åæå€ïŒC15H11NO5 èšç®å€ïŒïŒ£ïŒ63.16ïŒïŒšïŒ3.89ïŒïŒ®ïŒ4.91 å®æž¬å€ïŒïŒ£ïŒ63.15ïŒïŒšïŒ3.89ïŒïŒ®ïŒ4.90 å®æœäŸ ïŒ ïŒâïŒïŒâã¯ãããã³ãŸã€ã«ïŒâïŒâãããã
ã³ãŒã³é ¢é ž 20ïŒ ç¡«é ž40mlãšé ¢é ž40mlã«ïŒâãïŒâïŒïŒâã¯
ãããã³ãŸã€ã«ïŒâïŒâãããããšãã«ãããã
ã³äºé žãžãšãã«ãšã¹ãã«6.9ïœïŒ0.017ã¢ã«ïŒããš
ããã溶液ãçªçŽ é°å²æ°äžã«ïŒæ©éæµå ç±ããã
åå¿æ··åç©ãå·åŽããæåºããåºäœãåããïŒ
ïŒ éçé žãããªãŠã 150mläžã§æ¹æããããã®æ··
åç©ãéãã液ãæ¿ç¡«é žã§é žæ§ã«ãããæåº
ããçœè²åºäœãåããã€ãœãããããŒã«æ°Žæº¶æ¶²
ããåçµæ¶ããŠã3.2ïœïŒ61ïŒ ïŒã®çœè²éç¶çµæ¶
ãåŸããèç¹164ã165âã åæå€ïŒC15H10ClNO5 èšç®å€ïŒïŒ£ïŒ56.35ïŒïŒšïŒ3.15ïŒïŒ®ïŒ4.38 å®æž¬å€ïŒïŒ£ïŒ56.56ïŒïŒšïŒ3.10ïŒïŒ®ïŒ4.52 å®æœäŸ ïŒ ïŒâãã³ãŸã€ã«âïŒâãããïŒÎ±âã¡ãã«ïŒã
ã³ãŒã³é ¢é ž ïŒâïŒïŒâãã³ãŸã€ã«âïŒâãããããšãã«ïŒ
âïŒâã¡ãã«ãããã³äºé žãžãšãã«ãšã¹ãã«3.0
ïœïŒ0.0075ã¢ã«ïŒãé ¢é ž20mlããã³20ïŒ ç¡«é ž20ml
ãããªãæ··åç©ãçªçŽ é°å²æ°äžã«ïŒæ©éæµå ç±ã
ããåŸãããé»ããã 溶液ãæ¿çž®ããæ®æž£ã2N
çé žã«ãªãŠã 200mlã§åŠçããããã®æ··åç©ããž
ãšãã«ãšãŒãã«ãšå ±ã«æ©ç ããéããŠãäžæº¶ç©
ãé€å»ããã液ãå±€åé¢ããæ°Žå±€ããžãšãã«ãš
ãŒãã«ã§æŽæµããããã®æ°Žæº¶æ¶²ã掻æ§çã§åŠç
ããã»ã©ã€ãã«ããéãã液ãæ¿æµé ž13mlã§
é žæ§ã«ãããæåºããåºäœãåããïŒâããã
ããŒã«æ°Žæº¶æ¶²ããåçµæ¶ããŠã0.4ïœïŒ18ïŒ ïŒã®
çœè²ç²æ«ãåŸããèç¹177ã179âã åæå€ïŒC16H13NO3 èšç®å€ïŒïŒ£ïŒ64.21ïŒïŒšïŒ4.38ïŒïŒ®ïŒ4.61 å®æž¬å€ïŒïŒ£ïŒ64.43ïŒïŒšïŒ4.44ïŒïŒ®ïŒ4.71 å®æœäŸ ïŒ ïŒâãã³ãŸã€ã«âïŒâãããããšãã«ã¢ã»ãã¢
ãã ïŒâãã³ãŸã€ã«âïŒâããããã³ãŒã³é ¢é ž8.1
ïœïŒ0.028ã¢ã«ïŒãå¡©åããªãã«50mlããã³ãã³ãŒ
ã³50mlãããªãæ··åç©ãïŒæ©éæµå ç±ãããåŸã
ããé»ããã 溶液ãæ¿çž®ããæ®æž£ããã³ãŒã³ã§ïŒ
åæŽã€ãŠã8.1ïœïŒ94ïŒ ïŒã®é žå¡©åç©ãæ²¹ç¶ç©ãš
ããŠåŸãããã®é žå¡©åç©4.0ïœïŒ0.013ã¢ã«ïŒãã
ãã©ããããã©ã³20mlã«ãšããã溶液ããæ¿ãã
æ¹æããªããæ¿æ°Žé žåã¢ã³ã¢ããŠã 50mlã«å ã
ãããã®æ··åç©ã宀枩ã§ïŒæéæ¹æããåŸãå·æ°Ž
200mlãå ãããæ··åç©ãå75mlã®ãžãšãã«ãšãŒ
ãã«ã§ïŒåæœåºããåããããžãšãã«ãšãŒãã«æœ
åºæ¶²ãæ°ŽæŽããç¡«é žãããªãŠã ã§ä¹Ÿç¥ããæ¿çž®ã
ãŠãç²è£œã®ã¢ãããã¬ã ç¶ã§åŸãããã®ç²è£œç©ã¯
ïŒæ©æŸçœ®ãããšçµæ¶åããããã®åºäœããã³ãŒã³
ããåçµæ¶ããŠã14ïœïŒ38ïŒ ïŒã®çæç©ãåŸãã
èç¹137ã139âïŒå解ïŒã åæå€ïŒC15H12N2O4 èšç®å€ïŒïŒ£ïŒ63.38ïŒïŒšïŒ4.26ïŒïŒ®ïŒ9.85 å®æž¬å€ïŒïŒ£ïŒ63.24ïŒïŒšïŒ4.17ïŒïŒ®ïŒ9.72 å®æœäŸ ïŒ ïŒâãã³ãŸã€ã«âïŒâãããããšãã«é ¢é žãšã
ã« ïŒâãã³ãŸã€ã«âïŒâããããã³ãŒã³é ¢é žã®é ž
å¡©åç©ãå®æœäŸïŒãšåæ§ã«èª¿è£œãããTHF10ml
äžã®åŸãããé žå¡©åç©2.0ïœïŒ0.006ã¢ã«ïŒã®æº¶æ¶²
ããç¡æ°Žãšãã«ã¢ã«ã³ãŒã«50mlããã³ããªãšãã«
ã¢ãã³ïŒmlã§åŠçããããã®æ··åç©ã宀枩ã§ïŒæ
éæ¹æããæ¿çž®ããæ®æž£ãå¡©åã¡ãã¬ã³ãšæ°Žãšã®
éã§åé ãããå¡©åã¡ãã¬ã³å±€ãç¡«é žãããªãŠã
ã§ä¹Ÿç¥ããæ¿çž®ããŠãé»ããã ã¬ã ç¶ã®æ®æž£ãåŸ
ãããã®æ®æž£ããžãšãã«ãšãŒãã«ã«æº¶è§£ããé
ããŠãé»ããã äžæº¶æ§ã®äžçŽç©ãé€å»ããã液
ãæ¿çž®ããŠãã¬ã ç¶ã®æ®æž£ãåŸãããã®æ®æž£ã¯ïŒ
é±éã®æŸçœ®åŸã«æçµçã«ã¯çµæ¶åããããã®åºäœ
ãã€ãœãããã«ã¢ã«ã³ãŒã«ããïŒååçµæ¶ãïŒæŽ»
æ§çåŠçã䜵çšïŒã0.4ïœïŒ19ïŒ ïŒã®æ·¡é»è²ç²æ«ã
åŸããèç¹83ã85âã åæå€ïŒC17H15NO5 èšç®å€ïŒïŒ£ïŒ65.17ïŒïŒšïŒ4.83ïŒïŒ®ïŒ4.47 å®æž¬å€ïŒïŒ£ïŒ65.05ïŒïŒšïŒ4.83ïŒïŒ®ïŒ4.46 åèäŸ ïŒ å®æœäŸïŒã®æ¹æ³ã«ãããã€ãŠããã ãïŒïŒâã¯
ããâïŒâãããããšãã«ïŒïŒïŒâã¯ããããš
ãã«ïŒã¡ã¿ãã³ã«ä»£ããŠçã¢ã«éã®äžèšåå
ç©ïŒ ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒïŒïŒ
âãžã¯ããããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒâã¡
ãã«ããšãã«ïŒã¡ã¿ãã³ã ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒâã¡
ããã·ããšãã«ïŒã¡ã¿ãã³ãããã³ ïŒïŒâã¯ããâïŒâãããããšãã«ïŒïŒïŒâã
ããããšãã«ïŒã¡ã¿ãã³ã ã䜿çšãããšãäžèšçæç©ïŒ ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãããã³ãŸã€ã«ïŒâ
ïŒâãããããšãã«ããããã³äºé žãžãšãã«ãšã¹
ãã«ã ïŒâãïŒâïŒïŒâã¡ãã«ãã³ãŸã€ã«ïŒâïŒâã
ããããšãã«ããããã³äºé žãžãšãã«ãšã¹ãã«ã ïŒâãïŒâïŒïŒâã¡ããã·ãã³ãŸã€ã«ïŒâïŒâ
ãããããšãã«ããããã³äºé žãžãšãã«ãšã¹ã
ã«ã ããã³ ïŒâãïŒâïŒïŒâããããã³ãŸã€ã«ïŒâïŒâã
ããããšãã«ããããã³äºé žãžãšãã«ãšã¹ãã«ã ãåŸãããã åèäŸ ïŒ å®æœäŸïŒã®æ¹æ³ã«ãããã€ãŠããã ãïŒâïŒïŒ
âãã³ãŸã€ã«âïŒâãããããšãã«ïŒãããã³
äºé žã«ä»£ããŠçã¢ã«éã®äžèšååç©ïŒ ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãããã³ãŸã€ã«ïŒâ
ïŒâãããããšãã«ããããã³äºé žãžãšãã«ãšã¹
ãã«ã ïŒâãïŒâïŒïŒâã¡ãã«ãã³ãŸã€ã«ïŒâïŒâã
ããããšãã«ããããã³äºé žãžãšãã«ãšã¹ãã«ã ïŒâãïŒâïŒïŒâã¡ããã·ãã³ãŸã€ã«ïŒâïŒâ
ãããããšãã«ããããã³äºé žãžãšãã«ãšã¹ã
ã«ã ããã³ ïŒâãïŒâïŒïŒâããããã³ãŸã€ã«ïŒâïŒâã
ããããšãã«ããããã³äºé žãžãšãã«ãšã¹ãã«ã ã䜿çšãããšãäžèšçæç©ïŒ ïŒâïŒïŒïŒïŒâãžã¯ãããã³ãŸã€ã«ïŒâïŒâã
ãããã³ãŒã³é ¢é žã ïŒâïŒïŒâã¡ãã«ãã³ãŸã€ã«ïŒâïŒâãããã
ã³ãŒã³é ¢é žã ïŒâïŒïŒâã¡ããã·ãã³ãŸã€ã«ïŒâïŒâããã
ãã³ãŒã³é ¢é žãããã³ ïŒâïŒïŒâããããã³ãŸã€ã«ïŒâïŒâãããã
ã³ãŒã³é ¢é žã ãåŸãããã æ¬çºæã¯ãæ¬çºæã®ååç©ãæå¹æåãšããŠå«
æããæ°èŠãªæ²»ççšçµæç©ãå å«ãããååºã®è¬
çåŠçã«æŽ»æ§ãªä»»æã®ååç©ã®æå¹éããåçš®ã®
çµè·¯ãããããšãã°ã«ãã»ã«å€ãããã¯é å€ã®åœ¢
æ ã§ã®çµå£æäžãæ» è溶液ãããã¯æžæ¿æ¶²ã®åœ¢æ
ã§ã®éçµå£æäžãæãã¯å Žåã«ãã€ãŠã¯æ» è溶液
ã®åœ¢æ ã§ã®æ³šèå æäžã«ããæäžã§ãããæ¬çºæ
ã®æ°èŠååç©ã®åœ¢æã«ããã€ãŠã¯ãæå¹æåãé©
åœãªæ äœãäžè¬çã«ã¯è£œå€çšæ äœã«æ··å ¥ãããæ¬
çºæã®çµæç©ã®èª¿è£œã«æçšãªå¥œé©ãªè£œå€çšæ äœã®
äŸãšããŠã¯ãã§ãã·ãããŒã©ãã³ããããŠç³ïŒã°
ã«ã³ãŒã¹ïŒãçé žãã°ãã·ãŠã ãä¹³ç³ã麊èœãªã©
ãæããããã液äœçµæç©ãæ¬çºæã®ç¯å²å ã§ã
ã€ãŠã奜é©ãªæ¶²ç¶ã®è£œå€çšæ äœã«ã¯ãšãã«ã¢ã«ã³
ãŒã«ããããã¬ã³ã°ãªã³ãŒã«ãã°ãªã»ãªã³ããã
ãŠç³ã·ããããªã©ãããã æ¬çºæã®è¬çåŠç掻æ§ååç©ã¯ãæäžãã人ã
ããã¯åç©ã®äœéã«å¿ããŠ0.1ã250mgæãã¯ãã
以äžã®åäœçšéã§æå©ã«äœ¿çšããããããšãã°ã
銬ã®ãããªå€§ååç©ã¯æå¹æå500ã1000mgã®é
å€ãå¿ èŠãšãããããã®ãããªåäœçšéã¯ïŒæ¥ã«
é©åœãªåæ°ã ãæäžãããããããã€ãŠãæ¥çšé
ã¯0.3ã450mgã®ç¯å²å ãšãªãããšãå€ããïŒåã®
æäžã«ã€ãïŒã25mgãæé©ã§ãããšæãããã å¯äžã®å¿ èŠãªæ¡ä»¶ã¯ãæå¹æåãæå¹éã ãå
åšãããããªãã¡ã䜿çšããå€åœ¢ãšççŸããã«é©
åœãªæå¹çšéãåŸãããããã«ãããšããããšã§
ãããåã ã®å ·äœäŸã§ã®å³å¯ãªçšéããã³æ¥çšé
ã¯ããã¡ããå»åž«ãŸãã¯ç£å»ã®æ瀺ã®ããšã«æšæº
çãªå»åŠåçã«ãããã€ãŠæ±ºå®ããããã æ¬çºæã®æå¹è¬å€ã¯ãä»ã®è¬çåŠçã«æŽ»æ§ãªè¬
å€æãã¯ç·©è¡å€ãå¶é žå€ãªã©ãšçµã¿åãããŠæäž
ããããšãã§ããçµæç©äžã®æ¬çºæã®æå¹è¬å€ã®
å²åã¯åºç¯å²ã«ãããã 以äžã«ãæ¬çºæã®çµæç©ã®å ·äœäŸãäŸç€ºããã (1) ã«ãã»ã«å€ ïŒã«ãã»ã«ã«ã€ãæå¹æåïŒmgã25mgãããã³
50mgã®ã«ãã»ã«å€ã調補ããããæå¹æåã®éã
å€ãå Žåã«ã¯ãä¹³ç³ã®éã§èª¿æŽããããšãã§ã
ãã ãè¡šã å¥ã®ã«ãã»ã«çšçµæç©ãšããŠãããå€éã®æå¹
æåãå«æããã®ã«é©ããçµæç©ã®äŸã次ã«ç€º
ãã ãè¡šã ãããã®å Žåãã䜿çšããæå¹æåãä¹³ç³ãã§
ãã·ãããã³ã¹ãã¢ãªã³é žãã°ãã·ãŠã ãšåäžã«
æ··åããæ··åç©ãã«ãã»ã«ã«å å¡«ããã (2) é å€ ïŒé å€åœã5.0mgã®æå¹æåãå«æããé å€çš
ã®ä»£è¡šçãªçµæç©ã次ã«ç€ºãããã®çµæã¯ããªã³
é žäºã«ã«ã·ãŠã ã®éã調æŽããããšã«ããæå¹æ
åã®å䟡ãç°ãªãå Žåã«ãå¿çšã§ããã ïŒé åœãïŒmgïŒ (a) æå¹æå 5.0 (b) ã³ãŒã³ã¹ã¿ãŒã 13.6 (c) ã³ãŒã³ã¹ã¿ãŒãïŒããŒã¹ãïŒ 3.4 (d) ä¹³ç³ 79.2 (e) ãªã³é žäºã«ã«ã·ãŠã 68.0 (f) ã¹ãã¢ãªã³é žã«ã«ã·ãŠã 0.9 170.1mg (a)ã(b)ã(d)ããã³(e)ãåäžã«æ··åããã(c)ã10
ïŒ æ°Žæ§ããŒã¹ããšããŠèª¿è£œãããäžèšæ··åç©ãã§
ãã·ãããŒã¹ããšå ±ã«é¡ç²åãã湿ã€ãé¡ç²ãïŒ
ã¡ãã·ãŠã®ãµããã«éãã湿ã€ãé¡ç²ã也ç¥ãã
ãåŸã12ã¡ãã·ãŠã®ãµããã«éããŠç²åºŠãããã
ãã也ç¥ããé¡ç²ãã¹ãã¢ãªã³é žã«ã«ã·ãŠã ãšæ··
åããæé ããã (3) ïŒïŒ æ» è泚å°æ¶² ïŒc.c.åœã æå¹æå 20mg é²è å€ïŒäŸãã¯ãããã¿ããŒã«ïŒ 0.5WïŒïŒ¶ïŒ 泚å°çšèžçæ°Žãå ã㊠ïŒc.c. äžèšçµæã®æº¶æ¶²ã調補ããéã«ããæž æŸåã
ãåŸãã¬ã©ã¹ã³ãã«å å¡«ããå¯å°ããå§ç±æ» èã
ãã 以äžã«æ¬çºæã詳述ããããåçš®ã®å€æŽãªãã³
ã«åçç©ããã³åçæ段ãåœæ¥è ã«ã¯æããã§ã
ã€ãŠãæ¬çºæã®ç¯å²ãéžè±ããã«æ¬çºæã®åå
ç©ãçµæç©ããã³æ¹æ³ã«ãããŠå®æœã§ããããšã¯
ç解ããããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒ ïŒåŒäžãR1ã¯æ°ŽçŽ ãŸãã¯äœçŽã¢ã«ãã«ã§ããã
R2ã¯OHãOMãâäœçŽã¢ã«ãã«ãNH2ãNH
âäœçŽã¢ã«ãã«ãŸãã¯ïŒ®ïŒïŒ®âãžäœçŽã¢ã«ãã«ã§
ããã ã¯æ°ŽçŽ ãŸãã¯ããã²ã³ã§ããã ïŒã¯å»è¬ãšããŠèš±å®¹ãããã«ããªã³ãããã¯å€
䟡ã«ããªã³ã®å Žåã«ã¯ã«ããªã³ã®äžéšåããŸãã¯
ãããã®æ°Žåç©ã§ããã ïœã¯ïŒãïŒã®æŽæ°ãããããæå³ããïŒã§è¡šã
ãããååç©ã ïŒ ïŒâãã³ãŸã€ã«âïŒâããããã³ãŒã³é ¢é žã§
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ïŒâïŒïŒâã¯ãããã³ãŸã€ã«ïŒâïŒâããã
ãã³ãŒã³é ¢é žã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ã ïŒ ïŒâãã³ãŸã€ã«âïŒâãããâïŒÎ±âã¡ã
ã«ïŒãã³ãŒã³é ¢é žã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èš
èŒã®ååç©ã ïŒ ïŒâãã³ãŸã€ã«âïŒâãããããšãã«ã¢ã»ã
ã¢ããã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®åå
ç©ã ïŒ ïŒâãã³ãŸã€ã«âïŒâãããããšãã«é ¢é žãš
ãã«ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/086,195 US4254146A (en) | 1979-10-18 | 1979-10-18 | 3-Benzoyl-2-nitrophenylacetic acids, metal salts, amides and esters |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5681540A JPS5681540A (en) | 1981-07-03 |
| JPH0222059B2 true JPH0222059B2 (ja) | 1990-05-17 |
Family
ID=22196924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14554980A Granted JPS5681540A (en) | 1979-10-18 | 1980-10-17 | 33benzoyll22nitrophenylacetic acid* its metal salt* amide and esters |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4254146A (ja) |
| JP (1) | JPS5681540A (ja) |
| AU (1) | AU534384B2 (ja) |
| BE (1) | BE885700A (ja) |
| CA (1) | CA1146964A (ja) |
| CH (1) | CH648285A5 (ja) |
| DE (1) | DE3038966A1 (ja) |
| FR (1) | FR2467840A1 (ja) |
| GB (1) | GB2061274B (ja) |
| IL (1) | IL61210A (ja) |
| IT (1) | IT1133696B (ja) |
| NL (1) | NL8005750A (ja) |
| PH (1) | PH15693A (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5475034A (en) * | 1994-06-06 | 1995-12-12 | Alcon Laboratories, Inc. | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| AR030346A1 (es) | 2000-08-14 | 2003-08-20 | Alcon Inc | Metodo de tratamiento de desordenes neurodegenerativos de la retina y cabeza de nervio optico |
| AR030345A1 (es) * | 2000-08-14 | 2003-08-20 | Alcon Inc | Metodo de tratamiento de desordenes relacionados con angiogenesis |
| AU2002247284A1 (en) | 2001-04-02 | 2002-10-15 | Alcon, Inc. | Method of treating ocular inflammatory and angiogenesis-related disorders using an amide derivative of flubiprofen or ketorolac |
| US20030207941A1 (en) * | 2002-05-03 | 2003-11-06 | Bingaman David P. | Method of treating vascular endothelial growth factor mediated vascular disorders |
| US20030187072A1 (en) * | 2003-02-14 | 2003-10-02 | Kapin Michael A. | Method of treating angiogenesis-related disorders |
| TWI358290B (en) * | 2004-12-02 | 2012-02-21 | Alcon Inc | Topical nepafenac formulations |
| TW200812575A (en) * | 2006-04-28 | 2008-03-16 | Alcon Inc | Formulations containing amide derivatives of carboxylic acid NSAIDs for topical administration to the eye |
| US20080153818A1 (en) * | 2006-12-21 | 2008-06-26 | Bingaman David P | Methods for preventing inflammation during surgery |
| US20090105245A1 (en) * | 2006-12-21 | 2009-04-23 | Bingaman David P | Methods for treating macular edema and ocular angiogenesis using an anti-inflammatory agent and a receptor tyrosine kinase inhibitor |
| US20080153819A1 (en) * | 2006-12-21 | 2008-06-26 | Bingaman David P | Methods for treating macular edema and pathologic ocular angiogenesis using a neuroprotective agent and a receptor tyrosine kinase inhibitor |
| CN116554017A (zh) * | 2017-10-11 | 2023-08-08 | æµæ±çåå¶è¯æéå ¬åž | äžç§é ®åºåžæŽè¬éåŒååç©çäžæ¥å¶å€æ¹æ³ |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1226344A (ja) * | 1967-07-31 | 1971-03-24 | ||
| CH577461A5 (ja) * | 1975-08-13 | 1976-07-15 | Robins Co Inc A H |
-
1979
- 1979-10-18 US US06/086,195 patent/US4254146A/en not_active Expired - Lifetime
-
1980
- 1980-10-06 IL IL61210A patent/IL61210A/xx unknown
- 1980-10-09 PH PH24690A patent/PH15693A/en unknown
- 1980-10-14 BE BE0/202458A patent/BE885700A/fr not_active IP Right Cessation
- 1980-10-15 CH CH7707/80A patent/CH648285A5/fr not_active IP Right Cessation
- 1980-10-15 DE DE19803038966 patent/DE3038966A1/de active Granted
- 1980-10-17 AU AU63462/80A patent/AU534384B2/en not_active Ceased
- 1980-10-17 FR FR8022243A patent/FR2467840A1/fr active Granted
- 1980-10-17 NL NL8005750A patent/NL8005750A/nl not_active Application Discontinuation
- 1980-10-17 CA CA000362654A patent/CA1146964A/en not_active Expired
- 1980-10-17 GB GB8033628A patent/GB2061274B/en not_active Expired
- 1980-10-17 IT IT25409/80A patent/IT1133696B/it active
- 1980-10-17 JP JP14554980A patent/JPS5681540A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| IT1133696B (it) | 1986-07-09 |
| IL61210A (en) | 1985-07-31 |
| US4254146A (en) | 1981-03-03 |
| FR2467840A1 (fr) | 1981-04-30 |
| FR2467840B1 (ja) | 1984-03-30 |
| JPS5681540A (en) | 1981-07-03 |
| DE3038966C2 (ja) | 1989-12-28 |
| PH15693A (en) | 1983-03-11 |
| AU6346280A (en) | 1981-04-30 |
| BE885700A (fr) | 1981-02-02 |
| DE3038966A1 (de) | 1981-04-30 |
| NL8005750A (nl) | 1981-04-22 |
| IL61210A0 (en) | 1980-12-31 |
| GB2061274B (en) | 1983-10-19 |
| CH648285A5 (fr) | 1985-03-15 |
| GB2061274A (en) | 1981-05-13 |
| IT8025409A0 (it) | 1980-10-17 |
| CA1146964A (en) | 1983-05-24 |
| AU534384B2 (en) | 1984-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4126635A (en) | 2-amino-3-(5- and 6-)benzoylphenylacetic acids, esters and metal salts thereof | |
| JP3775796B2 (ja) | æçç掻æ§åã³ïŒåã¯é®ç掻æ§ãæããç¡é žãšã¹ãã«é¡åã³ãããã®è£œé æ¹æ³ | |
| JPS582936B2 (ja) | ïŒââã¢ãã€ã«ããâã«é ¢é žããã³ãã®å¡©é¡ã®è£œæ³ | |
| JPH0249294B2 (ja) | ||
| JPH0222059B2 (ja) | ||
| US4029815A (en) | Anti-diarrheal anthranilic acids | |
| US4503073A (en) | 2-Amino-3-(alkylthiobenzoyl)-phenylacetic acids | |
| JPH01301661A (ja) | æ°èŠããªãžã«èªå°äœ | |
| US4196292A (en) | 6-Substituted amiloride derivatives | |
| IE47960B1 (en) | Tetrazole derivatives | |
| KR100979077B1 (ko) | ë²€ìŠìì í íí©ë¬Œì ê³ ì²Ž ìŒ ë° ìŽë¥Œ í¬íšíë ìœì íì ì¡°ì±ë¬Œ | |
| SU1311618A3 (ru) | СпПÑПб пПлÑÑеМО пÑПОзвПЎМÑÑ Ð°Ð·ÑлеМа | |
| FR2476071A1 (fr) | Nouveaux acides 2-amino-3-(a-hydroxybenzyl)-phenylacetiques et leurs esters et amides, utiles notamment comme agents anti-inflammatoires, et compositions pharmaceutiques les contenant | |
| JPS6139304B2 (ja) | ||
| FR2492378A1 (fr) | Derives de type 6h-dibenzo(b,d) pyranne 6-substitues utiles notamment comme medicaments antiulcereux, immunomodulateurs et antiviraux et procedes de leur preparation | |
| US3966783A (en) | Compounds | |
| KR880002289B1 (ko) | 2-ìë¯žë ž-3-(í ë¡ë²€ì¡°ìŒ)-ë©ížíëììžížì° ë° ê·ž ì ë첎ì ì ì¡°ë°©ë² | |
| FR2465710A1 (fr) | Nouveaux amino-2 benzoyl-3 phenylacetamides et leurs homologues cycliques utiles comme medicaments et compositions therapeutiques et formes pharmaceutiques les contenant | |
| JPS6399057A (ja) | ã°ãªã·ã³èªå°äœ | |
| CH628014A5 (en) | Gamma-aryl-gamma-oxoisovaleric acids having antiphlogistic and antalgic properties | |
| JPH07103105B2 (ja) | ã€ã³ããŒã«èªå°äœåã³ãã®è£œé æ¹æ³ | |
| JPH0356473A (ja) | ã·ã¯ããªãã·ã²ããŒãŒãšïŒâãªããã·ã²ããŒãŒã®äºéé»å®³å€ã§ããæ°èŠãªïŒâã¢ããŒã€ã«âïŒâããããã·âïŒâã¡ãã«âãã³ãŸãã©ã³ | |
| FR2465733A1 (fr) | Nouveaux derives imidazolylethoxymethyliques de 1,3-dioxoloquinoleines utiles notamment comme medicaments antibacteriens et antifongiques, leur procede de preparation et compositions therapeutiques et formes pharmaceutiques les contenant | |
| US5489592A (en) | 3,4-dihydro-4-oxo-3-(2-propenyl)-1-phthalazineacetic acids and derivatives, their preparations and medicines containing them | |
| HU188239B (en) | Process for the production of new resorcinol-derivatives and of therapeutic preparations containing them |